ENTRY,NAME,PRODUCT,FORMULA,EXACT_MASS,MOL_WEIGHT,CLASS,REMARK,EFFICACY,INTERACTION,BRITE,DBLINKS,ATOM,BOND,///,COMMENT,REACTION,PATHWAY,ENZYME,MODULE,BRACKET,SYMBOL,GENES,REFERENCE
C00031 Compound,D-Glucose;Grape sugar;Dextrose;Glucose;D-Glucopyranose,,C6H12O6,180.0634,180.1559,,Same as: D00009,,,"Compounds with biological roles [BR:br08001]CarbohydratesMonosaccharidesAldosesC00031 D-GlucoseAnatomical Therapeutic Chemical (ATC) classification [BR:br08303]B BLOOD AND BLOOD FORMING ORGANSB05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONSB05C IRRIGATING SOLUTIONSB05CX Other irrigating solutionsB05CX01 GlucoseD00009 Glucose (JP18) &lt;JP&gt;V VARIOUSV04 DIAGNOSTIC AGENTSV04C OTHER DIAGNOSTIC AGENTSV04CA Tests for diabetesV04CA02 GlucoseD00009 Glucose (JP18) &lt;JP&gt;V06 GENERAL NUTRIENTSV06D OTHER NUTRIENTSV06DC CarbohydratesV06DC01 GlucoseD00009 Glucose (JP18) &lt;JP&gt;Therapeutic category of drugs in Japan [BR:br08301]3 Agents affecting metabolism32 Nutrients, tonics323 Saccharide preparations3231 GlucosesD00009 Glucose (JP18); Purified glucose (JP18)Risk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsInorganic and organic chemicalsGlucoseD00009 Glucose (JP18)Animal drugs in Japan [BR:br08331]96 Agents affecting metabolism964 Saccharide preparations and blood substitutes9641 Dextrose and preparationsC00031 D-GlucoseDrugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD00009 GlucoseD00009 Purified glucoseD00009 Glucose injection",CAS: 50-99-7 2280-44-6PubChem: 3333ChEBI: 4167KNApSAcK: C00042470PDB-CCD: BGC GLC3DMET: B04623NIKKAJI: J4.109B,121 C1y C 24.2781 -16.53722 C1y C 24.2781 -17.93773 O2x O 25.4860 -15.83704 C1b C 23.0643 -15.83705 C1y C 25.4860 -18.63796 O1a O 23.0643 -18.63797 C1y C 26.7055 -16.53728 O1a O 22.0023 -16.74749 C1y C 26.7055 -17.937710 O1a O 25.4860 -20.038311 O1a O 27.9134 -15.837012 O1a O 27.9134 -18.6379,121 1 2 12 1 3 13 1 4 1 #Up4 2 5 15 2 6 1 #Down6 3 7 17 4 8 18 5 9 19 5 10 1 #Up10 7 11 1 #Either11 9 12 1 #Down12 7 9 1,,alpha-D-Glucose [CPD:C00267]beta-D-Glucose [CPD:C00221],R00010 R00015 R00028 R00049 R00063 R00299 R00300 R00301R00302 R00303 R00304 R00305 R00306 R00308 R00327 R00337R00503 R00534 R00550 R00725 R00801 R00837 R00838 R00839R00850 R00874 R00952 R00953 R00960 R01006 R01100 R01101R01139 R01444 R01460 R01498 R01555 R01718 R01790 R01791R02185 R02558 R02595 R02727 R02738 R02887 R02985 R03075R03323 R03527 R03604 R03703 R03801 R03802 R03820 R04006R04094 R04194 R04333 R04409 R04410 R04411 R04498 R04503R04949 R04998 R05061 R05140 R05141 R05142 R05196 R05804R05980 R05981 R06040 R06053 R06056 R06058 R06059 R06067R06069 R06079 R06080 R06087 R06091 R06103 R06104 R06105R06106 R06107 R06108 R06109 R06112 R06113 R06114 R06115R06135 R06204 R06620 R07147 R07264 R08404 R08432 R08514R08819 R08823 R08946 R09039 R09723 R09941 R09943 R10411R10494 R10525 R10530 R10580 R10581 R11215 R11306 R11682R11791 R11942 R12208 R12209 R12250 R12983 R12997,"map00010 Glycolysis / Gluconeogenesismap00030 Pentose phosphate pathwaymap00052 Galactose metabolismmap00500 Starch and sucrose metabolismmap00520 Amino sugar and nucleotide sugar metabolismmap00521 Streptomycin biosynthesismap00524 Neomycin, kanamycin and gentamicin biosynthesismap00901 Indole alkaloid biosynthesismap01100 Metabolic pathwaysmap01110 Biosynthesis of secondary metabolitesmap02010 ABC transportersmap02020 Two-component systemmap02060 Phosphotransferase system (PTS)map04066 HIF-1 signaling pathwaymap04068 FoxO signaling pathwaymap04113 Meiosis - yeastmap04152 AMPK signaling pathwaymap04742 Taste transductionmap04910 Insulin signaling pathwaymap04911 Insulin secretionmap04917 Prolactin signaling pathwaymap04922 Glucagon signaling pathwaymap04930 Type II diabetes mellitusmap04931 Insulin resistancemap04932 Non-alcoholic fatty liver diseasemap04933 AGE-RAGE signaling pathway in diabetic complicationsmap04973 Carbohydrate digestion and absorptionmap04976 Bile secretionmap04978 Mineral absorptionmap05111 Biofilm formation - Vibrio choleraemap05230 Central carbon metabolism in cancermap05415 Diabetic cardiomyopathy",1.1.1.118 1.1.1.119 1.1.1.121 1.1.1.3591.1.1.360 1.1.1.432 1.1.3.10 1.1.5.21.1.5.9 1.1.99.28 1.1.99.35 2.3.1.722.3.1.90 2.3.1.91 2.3.1.92 2.3.1.1032.3.1.143 2.3.1.152 2.3.1.- 2.4.1.82.4.1.9 2.4.1.10 2.4.1.20 2.4.1.222.4.1.25 2.4.1.31 2.4.1.64 2.4.1.992.4.1.230 2.4.1.245 2.4.1.279 2.4.1.2812.7.1.1 2.7.1.2 2.7.1.41 2.7.1.422.7.1.61 2.7.1.62 2.7.1.63 2.7.1.1422.7.1.147 2.7.1.199 3.1.1.33 3.1.3.93.1.3.10 3.1.3.58 3.1.4.48 3.1.6.33.2.1.3 3.2.1.10 3.2.1.20 3.2.1.213.2.1.22 3.2.1.23 3.2.1.26 3.2.1.283.2.1.39 3.2.1.42 3.2.1.45 3.2.1.483.2.1.58 3.2.1.74 3.2.1.86 3.2.1.933.2.1.104 3.2.1.105 3.2.1.107 3.2.1.1083.2.1.117 3.2.1.118 3.2.1.122 3.2.1.1253.2.1.126 3.2.1.147 3.2.1.175 3.2.1.1823.2.1.186 3.2.1.188 3.2.1.189 3.2.1.2053.2.1.206 3.2.1.207 3.2.1.208 3.2.1.2163.2.1.- 4.2.99.22 4.2.99.23,,,,,
C00089 Compound,Sucrose;Cane sugar;Saccharose;1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside,,C12H22O11,342.1162,342.2965,,Same as: D00025 G00370,,,"Compounds with biological roles [BR:br08001]CarbohydratesOligosaccharidesDisaccharidesC00089 Sucrose; Cane sugarTherapeutic category of drugs in Japan [BR:br08301]7 Agents not mainly for therapeutic purpose71 Dispensing medicines714 Flavorings, deodorants, coloring agents7149 OthersD00025 Sucrose (JP18/NF); White soft sugar (JP18); Sugar, compressible (NF); Sugar, confectioner's (NF); Sugar spheres (NF)Risk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsInorganic and organic chemicalsWhite soft sugarD00025 Sucrose (JP18/NF)Drugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD00025 White soft sugarD00025 Sucrose",CAS: 57-50-1PubChem: 3389ChEBI: 17992KNApSAcK: C00001151PDB-CCD: SUC3DMET: B01156NIKKAJI: J4.581K,231 C1z C 27.5095 -14.68902 O2a O 26.4715 -15.61603 O2x O 28.6757 -13.84924 C1y C 27.9351 -15.98925 C1b C 26.5299 -13.69186 C1y C 25.2645 -16.31587 C1y C 29.8012 -14.66568 C1y C 29.3521 -15.98929 O1a O 27.1130 -17.126310 O1a O 25.2528 -14.274811 O2x O 24.0400 -15.616012 C1y C 25.2645 -17.715313 C1b C 31.1365 -14.245714 O1a O 30.1628 -17.132215 C1y C 22.8387 -16.321716 C1y C 24.0400 -18.415017 O1a O 26.4656 -18.415018 O1a O 31.9762 -15.371119 C1y C 22.8387 -17.715320 C1b C 21.6259 -15.616021 O1a O 24.0400 -19.814522 O1a O 21.6259 -18.415023 O1a O 20.5586 -16.5258,241 1 2 1 #Down2 1 3 13 1 4 14 1 5 15 6 2 1 #Down6 3 7 17 4 8 18 4 9 1 #Down9 5 10 110 6 11 111 6 12 112 7 13 1 #Down13 8 14 1 #Up14 11 15 115 12 16 116 12 17 1 #Down17 13 18 118 15 19 119 15 20 1 #Up20 16 21 1 #Up21 19 22 1 #Down22 20 23 123 7 8 124 16 19 1,,,R00015 R00039 R00801 R00802 R00803 R00805 R00806 R00807R00808 R00809 R00810 R00811 R01103 R01823 R02120 R02411R04194 R05140 R07256 R08616 R08676 R12349 R12527 R12528,map00052 Galactose metabolismmap00500 Starch and sucrose metabolismmap01100 Metabolic pathwaysmap01110 Biosynthesis of secondary metabolitesmap02010 ABC transportersmap02060 Phosphotransferase system (PTS)map04742 Taste transductionmap04973 Carbohydrate digestion and absorption,1.1.99.13 2.4.1.4 2.4.1.5 2.4.1.72.4.1.9 2.4.1.10 2.4.1.13 2.4.1.822.4.1.99 2.4.1.125 2.4.1.166 2.4.1.1672.4.1.362 2.4.1.372 2.4.1.373 2.7.1.2113.1.3.24 3.2.1.10 3.2.1.20 3.2.1.223.2.1.26 3.2.1.48 5.4.99.11,,,,,
C00794 Compound,D-Sorbitol;D-Glucitol;L-Gulitol;Sorbitol,,C6H14O6,182.079,182.1718,,Same as: D00096,,,Compounds with biological roles [BR:br08001]CarbohydratesMonosaccharidesSugar alcoholsC00794 SorbitolAnatomical Therapeutic Chemical (ATC) classification [BR:br08303]A ALIMENTARY TRACT AND METABOLISMA06 DRUGS FOR CONSTIPATIONA06A DRUGS FOR CONSTIPATIONA06AD Osmotically acting laxativesA06AD18 SorbitolD00096 Sorbitol solution (USP) &lt;JP/US&gt;A06AG EnemasA06AG07 SorbitolD00096 Sorbitol solution (USP) &lt;JP/US&gt;B BLOOD AND BLOOD FORMING ORGANSB05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONSB05C IRRIGATING SOLUTIONSB05CX Other irrigating solutionsB05CX02 SorbitolD00096 Sorbitol solution (USP) &lt;JP/US&gt;V VARIOUSV04 DIAGNOSTIC AGENTSV04C OTHER DIAGNOSTIC AGENTSV04CC Tests for bile duct patencyV04CC01 SorbitolD00096 Sorbitol solution (USP) &lt;JP/US&gt;Therapeutic category of drugs in Japan [BR:br08301]2 Agents affecting individual organs25 Urogenital and anal organ agents251 Urinary organ agents2519 OthersD00096 Sorbitol solution (USP); D-Sorbitol (JP18); Sorbitol (NF)7 Agents not mainly for therapeutic purpose79 Other agents not mainly for therapeutic purpose799 Miscellaneous7990 MiscellaneousD00096 Sorbitol solution (USP); D-Sorbitol (JP18); Sorbitol (NF)Risk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsInorganic and organic chemicalsD-SorbitolD00096 Sorbitol solution (USP)Drugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD00096 D-SorbitolD00096 D-Sorbitol solution,CAS: 50-70-4PubChem: 4052ChEBI: 17924KNApSAcK: C00001173PDB-CCD: SOR3DMET: B04724NIKKAJI: J2.299C,121 O1a O 20.7200 -7.49002 C1b C 21.9324 -6.79003 C1c C 23.1449 -7.49004 C1c C 24.3573 -6.79005 C1c C 25.5697 -7.49006 C1c C 26.7822 -6.79007 C1b C 27.9946 -7.49008 O1a O 29.2070 -6.79009 O1a O 23.1449 -8.889810 O1a O 24.3573 -5.390011 O1a O 25.5697 -8.889912 O1a O 26.7822 -5.3903,111 1 2 12 2 3 13 3 4 14 4 5 15 5 6 16 6 7 17 7 8 18 3 9 1 #Up9 4 10 1 #Up10 5 11 1 #Up11 6 12 1 #Down,,,R00874 R00875 R01697 R01787 R02865 R02866 R02867 R02868R02925 R02926 R05820 R07346 R11620,map00051 Fructose and mannose metabolismmap00052 Galactose metabolismmap01100 Metabolic pathwaysmap02010 ABC transportersmap02060 Phosphotransferase system (PTS)map05415 Diabetic cardiomyopathy,1.1.1.14 1.1.1.15 1.1.1.21 1.1.1.2891.1.3.41 1.1.99.21 1.1.99.28 2.7.1.12.7.1.198 3.1.3.50 3.2.1.22,,,,,
C00392 Compound,Mannitol;D-Mannitol,,C6H14O6,182.079,182.1718,,Same as: D00062,,,"Compounds with biological roles [BR:br08001]CarbohydratesMonosaccharidesSugar alcoholsC00392 MannitolAnatomical Therapeutic Chemical (ATC) classification [BR:br08303]A ALIMENTARY TRACT AND METABOLISMA06 DRUGS FOR CONSTIPATIONA06A DRUGS FOR CONSTIPATIONA06AD Osmotically acting laxativesA06AD16 MannitolD00062 Mannitol (USP) &lt;JP/US&gt;B BLOOD AND BLOOD FORMING ORGANSB05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONSB05B I.V. SOLUTIONSB05BC Solutions producing osmotic diuresisB05BC01 MannitolD00062 Mannitol (USP) &lt;JP/US&gt;B05C IRRIGATING SOLUTIONSB05CX Other irrigating solutionsB05CX04 MannitolD00062 Mannitol (USP) &lt;JP/US&gt;R RESPIRATORY SYSTEMR05 COUGH AND COLD PREPARATIONSR05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTSR05CB MucolyticsR05CB16 MannitolD00062 Mannitol (USP) &lt;JP/US&gt;V VARIOUSV04 DIAGNOSTIC AGENTSV04C OTHER DIAGNOSTIC AGENTSV04CX Other diagnostic agentsV04CX04 MannitolD00062 Mannitol (USP) &lt;JP/US&gt;USP drug classification [BR:br08302]Respiratory Tract/Pulmonary AgentsCystic Fibrosis AgentsCystic Fibrosis Agents, OtherMannitolD00062 Mannitol (USP)Therapeutic category of drugs in Japan [BR:br08301]2 Agents affecting individual organs21 Cardiovascular agents219 Miscellaneous2190 MiscellaneousD00062 Mannitol (USP); D-Mannitol (JP18)Drugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD00062 D-MannitolD00062 D-Mannitol injectionNew drug approvals in Europe [br08329.html]European public assessment reports (EPAR) authorised medicineD00062",CAS: 69-65-8PubChem: 3682ChEBI: 16899KNApSAcK: C00001165PDB-CCD: MTL3DMET: B04676NIKKAJI: J2.369H,121 O1a O 19.3900 -6.65002 C1b C 20.6024 -5.95003 C1c C 21.8149 -6.65004 C1c C 23.0273 -5.95005 C1c C 24.2397 -6.65006 C1c C 25.4522 -5.95007 C1b C 26.6646 -6.65008 O1a O 27.8770 -5.95009 O1a O 21.8149 -8.049810 O1a O 25.4522 -4.550311 O1a O 23.0273 -4.550012 O1a O 24.2397 -8.0499,111 1 2 12 2 3 13 3 4 14 4 5 15 5 6 16 6 7 17 7 8 18 3 9 1 #Down9 6 10 1 #Down10 4 11 1 #Up11 5 12 1 #Up,,,R00865 R00868 R00870 R02167 R02704 R05698 R07135,map00051 Fructose and mannose metabolismmap01100 Metabolic pathwaysmap02010 ABC transportersmap02060 Phosphotransferase system (PTS),1.1.1.11 1.1.1.67 1.1.1.138 1.1.1.2551.1.2.2 1.1.3.40 2.7.1.197 3.1.3.22,,,,,
C00095 Compound,D-Fructose;Levulose;Fruit sugar;D-arabino-Hexulose,,C6H12O6,180.0634,180.1559,,,,,Compounds with biological roles [BR:br08001]CarbohydratesMonosaccharidesKetosesC00095 D-Fructose; Fruit sugarAnimal drugs in Japan [BR:br08331]96 Agents affecting metabolism964 Saccharide preparations and blood substitutes9642 Fructose and preparationsC00095 D-Fructose,CAS: 57-48-7PubChem: 3395ChEBI: 15824 37721KNApSAcK: C00033848PDB-CCD: FRU Z9N3DMET: B04631NIKKAJI: J4.580B,121 C1z C 23.3627 -14.90992 C1y C 22.9367 -16.20513 O2x O 22.2017 -14.06994 C1b C 24.3427 -13.90645 O1a O 24.6461 -15.37676 C1y C 21.5250 -16.20517 O1a O 23.7592 -17.34858 C1y C 21.0699 -14.88089 O1a O 25.6204 -14.495710 O1a O 20.7082 -17.354411 C1b C 19.7338 -14.460712 O1a O 18.8938 -15.5866,121 1 2 12 1 3 13 1 4 1 #Either4 1 5 15 2 6 16 2 7 1 #Up7 3 8 18 4 9 19 6 10 1 #Down10 8 11 1 #Up11 11 12 112 6 8 1,,D-Fructose (pyranose) [CPD:C05003]D-Fructose (open-chain) [CPD:C10906]L-Fructose [CPD:C01719],R00760 R00801 R00803 R00806 R00865 R00866 R00867 R00868R00870 R00872 R00873 R00874 R00875 R00876 R00877 R00878R00879 R01140 R01823 R02120 R02410 R03232 R03635 R03921R06034 R06036 R06052 R06066 R06087 R06100 R06101 R06208R08406 R08407 R08548 R08651 R08676 R10817 R12349 R12527R12528,map00051 Fructose and mannose metabolismmap00052 Galactose metabolismmap00500 Starch and sucrose metabolismmap01100 Metabolic pathwaysmap01110 Biosynthesis of secondary metabolitesmap01120 Microbial metabolism in diverse environmentsmap02010 ABC transportersmap02060 Phosphotransferase system (PTS)map04742 Taste transductionmap04931 Insulin resistancemap04973 Carbohydrate digestion and absorptionmap05415 Diabetic cardiomyopathy,1.1.1.11 1.1.1.14 1.1.1.15 1.1.1.671.1.1.124 1.1.1.138 1.1.2.2 1.1.5.141.1.99.28 2.4.1.4 2.4.1.5 2.4.1.72.4.1.13 2.4.1.125 2.4.1.362 2.4.1.3722.4.1.373 2.7.1.1 2.7.1.3 2.7.1.42.7.1.61 2.7.1.202 3.1.3.68 3.1.3.-3.2.1.10 3.2.1.20 3.2.1.26 3.2.1.483.2.1.80 5.1.3.30 5.1.3.31 5.3.1.55.3.1.7,,,,,
C00033 Compound,Acetate;Acetic acid;Ethanoic acid,,C2H4O2,60.0211,60.052,,Same as: D00010,,,"Compounds with biological roles [BR:br08001]Organic acidsCarboxylic acidsMonocarboxylic acidsC00033 Acetate; EthanoateLipids [BR:br08002]FA Fatty acylsFA01 Fatty Acids and ConjugatesFA0101 Straight chain fatty acidsC00033 Acetic acidAnatomical Therapeutic Chemical (ATC) classification [BR:br08303]G GENITO URINARY SYSTEM AND SEX HORMONESG01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICSG01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDSG01AD Organic acidsG01AD02 Acetic acidD00010 Acetic acid, glacial (USP) &lt;JP/US&gt;S SENSORY ORGANSS02 OTOLOGICALSS02A ANTIINFECTIVESS02AA AntiinfectivesS02AA10 Acetic acidD00010 Acetic acid, glacial (USP) &lt;JP/US&gt;USP drug classification [BR:br08302]AntibacterialsAntibacterials, OtherAcetic AcidD00010 Acetic acid, glacial (USP)Therapeutic category of drugs in Japan [BR:br08301]2 Agents affecting individual organs26 Epidermides264 Analgesics, anti-itchings, astringents, anti-inflammatory agents2649 OthersD00010 Acetic acid, glacial (USP); Acetic acid (JP18/NF); Glacial acetic acid (JP18)266 Emollients2661 Organic acidsD00010 Acetic acid, glacial (USP); Acetic acid (JP18/NF); Glacial acetic acid (JP18)7 Agents not mainly for therapeutic purpose71 Dispensing medicines714 Flavorings, deodorants, coloring agents7149 OthersD00010 Acetic acid, glacial (USP); Acetic acid (JP18/NF); Glacial acetic acid (JP18)719 Miscellaneous7190 MiscellaneousD00010 Acetic acid, glacial (USP); Acetic acid (JP18/NF); Glacial acetic acid (JP18)Risk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsInorganic and organic chemicalsAcetic acidD00010 Acetic acid, glacial (USP)Drugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD00010 Acetic acidD00010 Glacial acetic acid",CAS: 64-19-7PubChem: 3335ChEBI: 15366 30089LIPIDMAPS: LMFA01010002KNApSAcK: C00001176PDB-CCD: ACT ACY3DMET: B00009NIKKAJI: J2.355H,41 C6a C 24.5700 -15.75002 C1a C 25.7840 -16.45273 O6a O 23.3619 -16.45274 O6a O 24.5700 -14.3503,31 1 2 12 1 3 13 1 4 2,,,R00227 R00229 R00235 R00315 R00316 R00317 R00318 R00319R00320 R00321 R00322 R00324 R00325 R00326 R00327 R00338R00362 R00393 R00458 R00488 R00628 R00651 R00669 R00710R00711 R00743 R00897 R00909 R00928 R01019 R01026 R01156R01179 R01200 R01241 R01287 R01308 R01323 R01359 R01426R01649 R01810 R01987 R02026 R02059 R02276 R02333 R02733R02942 R02955 R03062 R03131 R03132 R03133 R03134 R03145R03153 R03217 R03482 R03601 R03884 R04000 R04043 R04056R04057 R04091 R04141 R04146 R04174 R04397 R04449 R04450R04452 R04490 R04525 R04587 R04727 R04769 R04859 R04945R05138 R05168 R05219 R05336 R05508 R05509 R05677 R05880R05917 R06241 R06893 R07183 R07300 R07301 R07342 R07513R07832 R08090 R08206 R08517 R08518 R08600 R08601 R08874R08876 R08895 R08901 R08944 R09107 R09475 R09483 R09651R09721 R09801 R09931 R10248 R10249 R10289 R10305 R10343R10398 R10401 R10461 R10553 R10600 R10614 R10705 R10839R10840 R11116 R11283 R11693 R11694 R11889 R11903 R12347R12390 R12391 R12392 R12515 R12516 R12635 R12671 R12926,map00010 Glycolysis / Gluconeogenesismap00430 Taurine and hypotaurine metabolismmap00440 Phosphonate and phosphinate metabolismmap00534 Glycosaminoglycan biosynthesis - heparan sulfate / heparinmap00620 Pyruvate metabolismmap00630 Glyoxylate and dicarboxylate metabolismmap00660 C5-Branched dibasic acid metabolismmap00680 Methane metabolismmap00720 Carbon fixation pathways in prokaryotesmap00908 Zeatin biosynthesismap00920 Sulfur metabolismmap01100 Metabolic pathwaysmap01110 Biosynthesis of secondary metabolitesmap01120 Microbial metabolism in diverse environmentsmap01200 Carbon metabolismmap01220 Degradation of aromatic compoundsmap04725 Cholinergic synapsemap04936 Alcoholic liver diseasemap04973 Carbohydrate digestion and absorptionmap04974 Protein digestion and absorption,1.1.1.318 1.1.1.319 1.2.1.3 1.2.1.41.2.1.5 1.2.1.- 1.2.5.1 1.2.5.21.2.99.6 1.13.11.50 1.13.12.4 1.14.13.541.14.14.32 2.1.1.152 2.3.1.187 2.5.1.472.5.1.48 2.5.1.49 2.5.1.50 2.5.1.512.5.1.52 2.5.1.53 2.5.1.65 2.5.1.1182.5.1.119 2.5.1.134 2.5.1.144 2.6.99.32.7.2.1 2.7.2.12 2.7.2.15 2.8.3.12.8.3.3 2.8.3.8 2.8.3.10 2.8.3.112.8.3.12 2.8.3.14 2.8.3.18 2.8.3.192.8.3.- 3.1.1.2 3.1.1.6 3.1.1.73.1.1.8 3.1.1.33 3.1.1.41 3.1.1.473.1.1.53 3.1.1.54 3.1.1.55 3.1.1.563.1.1.58 3.1.1.66 3.1.1.71 3.1.1.803.1.1.94 3.1.1.105 3.1.1.106 3.1.1.1123.1.1.113 3.1.1.114 3.1.2.1 3.1.2.163.5.1.4 3.5.1.14 3.5.1.15 3.5.1.163.5.1.17 3.5.1.21 3.5.1.25 3.5.1.293.5.1.33 3.5.1.41 3.5.1.47 3.5.1.483.5.1.51 3.5.1.62 3.5.1.63 3.5.1.663.5.1.76 3.5.1.85 3.5.1.89 3.5.1.1033.5.1.104 3.5.1.105 3.5.1.108 3.5.1.1123.5.1.113 3.5.1.114 3.5.1.125 3.5.1.1353.5.1.136 3.5.1.- 3.6.1.7 3.6.1.203.7.1.1 3.7.1.6 3.7.1.24 3.7.1.253.11.1.2 4.1.1.88 4.1.3.4 4.1.3.64.1.3.22 4.1.3.26 4.2.99.24 6.2.1.16.2.1.13 6.2.1.22 6.2.1.35,"M00357 Methanogenesis, acetate => methaneM00579 Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate",,,,
C00025 Compound,L-Glutamate;L-Glutamic acid;L-Glutaminic acid;Glutamate,,C5H9NO4,147.0532,147.1293,,Same as: D00007,,,Compounds with biological roles [BR:br08001]PeptidesAmino acidsCommon amino acidsC00025 Glutamic acid (Glu)Hormones and transmittersNeurotransmittersAmino acidsC00025 GlutamateRisk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsInorganic and organic chemicalsGlutamic acidD00007 Glutamic acid (USP)Drugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD00007 L-Glutamic acid,CAS: 56-86-0PubChem: 3327ChEBI: 16015KNApSAcK: C00001358PDB-CCD: GGL GLU3DMET: B00007NIKKAJI: J9.171E,101 C1c C 23.8372 -17.46082 C1b C 25.0252 -16.72333 C6a C 22.6023 -16.79944 N1a N 23.8781 -18.85955 C1b C 26.2601 -17.37886 O6a O 21.4434 -17.59547 O6a O 22.6198 -15.40078 C6a C 27.4482 -16.64149 O6a O 28.6830 -17.302810 O6a O 27.4714 -15.2426,91 1 2 12 1 3 13 1 4 1 #Down4 2 5 15 3 6 16 3 7 27 5 8 18 8 9 19 8 10 2,,,R00021 R00093 R00114 R00239 R00243 R00245 R00248 R00250R00251 R00253 R00254 R00256 R00257 R00258 R00259 R00260R00261 R00262 R00263 R00355 R00372 R00411 R00457 R00494R00525 R00573 R00575 R00578 R00609 R00667 R00668 R00684R00694 R00707 R00708 R00734 R00768 R00894 R00895 R00908R00942 R00986 R01072 R01090 R01155 R01161 R01214 R01231R01339 R01585 R01586 R01648 R01654 R01684 R01716 R01939R01956 R02040 R02077 R02199 R02237 R02274 R02282 R02283R02285 R02287 R02313 R02315 R02433 R02619 R02700 R02772R02773 R02929 R02930 R03053 R03120 R03189 R03207 R03243R03248 R03266 R03651 R03905 R03916 R03952 R03970 R03971R04028 R04029 R04051 R04171 R04173 R04188 R04212 R04217R04234 R04241 R04242 R04269 R04338 R04438 R04463 R04467R04475 R04529 R04558 R04776 R05052 R05085 R05197 R05207R05224 R05225 R05507 R05578 R05815 R06423 R06426 R06586R06631 R06634 R06977 R07275 R07276 R07277 R07396 R07414R07419 R07456 R07613 R07643 R07659 R08244 R08855 R08897R08903 R08905 R08906 R08931 R08956 R09195 R09399 R09400R09401 R09495 R09594 R09598 R09599 R09778 R09824 R09825R09875 R10086 R10089 R10094 R10141 R10153 R10460 R10677R10678 R10679 R10687 R10688 R10693 R10698 R10772 R10845R10902 R10929 R10932 R10991 R10993 R11021 R11118 R11269R11270 R11285 R11291 R11297 R11298 R11299 R11395 R11409R11475 R11515 R11561 R11607 R11627 R11705 R11792 R11793R11794 R11795 R11960 R11963 R12214 R12251 R12272 R12352R12410 R12412 R12590 R12606 R12663 R12688 R12728 R12730R12906 R12936 R12939,"map00220 Arginine biosynthesismap00250 Alanine, aspartate and glutamate metabolismmap00330 Arginine and proline metabolismmap00332 Carbapenem biosynthesismap00340 Histidine metabolismmap00430 Taurine and hypotaurine metabolismmap00470 D-Amino acid metabolismmap00480 Glutathione metabolismmap00524 Neomycin, kanamycin and gentamicin biosynthesismap00630 Glyoxylate and dicarboxylate metabolismmap00650 Butanoate metabolismmap00660 C5-Branched dibasic acid metabolismmap00860 Porphyrin metabolismmap00910 Nitrogen metabolismmap00970 Aminoacyl-tRNA biosynthesismap00997 Biosynthesis of various other secondary metabolitesmap00998 Biosynthesis of various antibioticsmap01060 Biosynthesis of plant secondary metabolitesmap01064 Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acidmap01100 Metabolic pathwaysmap01110 Biosynthesis of secondary metabolitesmap01120 Microbial metabolism in diverse environmentsmap01200 Carbon metabolismmap01210 2-Oxocarboxylic acid metabolismmap01230 Biosynthesis of amino acidsmap01240 Biosynthesis of cofactorsmap02010 ABC transportersmap02020 Two-component systemmap04068 FoxO signaling pathwaymap04072 Phospholipase D signaling pathwaymap04080 Neuroactive ligand-receptor interactionmap04216 Ferroptosismap04540 Gap junctionmap04713 Circadian entrainmentmap04720 Long-term potentiationmap04721 Synaptic vesicle cyclemap04723 Retrograde endocannabinoid signalingmap04724 Glutamatergic synapsemap04727 GABAergic synapsemap04730 Long-term depressionmap04742 Taste transductionmap04964 Proximal tubule bicarbonate reclamationmap04974 Protein digestion and absorptionmap05014 Amyotrophic lateral sclerosismap05016 Huntington diseasemap05017 Spinocerebellar ataxiamap05022 Pathways of neurodegeneration - multiple diseasesmap05030 Cocaine addictionmap05031 Amphetamine addictionmap05033 Nicotine addictionmap05034 Alcoholismmap05230 Central carbon metabolism in cancer",1.2.1.88 1.4.1.2 1.4.1.3 1.4.1.41.4.1.13 1.4.1.14 1.4.3.11 1.4.7.11.5.1.9 1.5.1.10 1.5.3.18 1.5.99.51.14.11.76 2.1.1.21 2.1.2.5 2.3.1.12.3.1.14 2.3.1.35 2.3.2.2 2.3.2.-2.4.2.14 2.5.1.140 2.6.1.1 2.6.1.22.6.1.3 2.6.1.4 2.6.1.5 2.6.1.62.6.1.7 2.6.1.8 2.6.1.9 2.6.1.112.6.1.13 2.6.1.16 2.6.1.17 2.6.1.192.6.1.22 2.6.1.23 2.6.1.24 2.6.1.262.6.1.27 2.6.1.29 2.6.1.33 2.6.1.342.6.1.36 2.6.1.38 2.6.1.39 2.6.1.402.6.1.42 2.6.1.44 2.6.1.48 2.6.1.492.6.1.52 2.6.1.55 2.6.1.57 2.6.1.592.6.1.65 2.6.1.67 2.6.1.72 2.6.1.752.6.1.76 2.6.1.79 2.6.1.80 2.6.1.812.6.1.82 2.6.1.83 2.6.1.85 2.6.1.862.6.1.87 2.6.1.89 2.6.1.90 2.6.1.922.6.1.93 2.6.1.94 2.6.1.95 2.6.1.982.6.1.102 2.6.1.103 2.6.1.104 2.6.1.1062.6.1.107 2.6.1.109 2.6.1.110 2.6.1.1112.6.1.114 2.6.1.116 2.6.1.118 2.6.1.1202.6.1.122 2.6.1.123 2.6.1.- 2.7.2.113.4.17.21 3.4.19.9 3.4.19.13 3.4.19.143.4.19.16 3.5.1.2 3.5.1.38 3.5.1.553.5.1.65 3.5.1.68 3.5.1.87 3.5.1.943.5.1.96 3.5.1.118 3.5.1.123 3.5.1.1293.5.2.9 3.5.3.8 4.1.1.15 4.1.3.274.2.1.168 4.3.2.10 4.3.3.6 5.1.1.35.4.3.9 5.4.99.1 6.1.1.17 6.1.1.246.2.1.39 6.2.1.68 6.3.1.2 6.3.1.66.3.1.11 6.3.1.17 6.3.1.18 6.3.2.26.3.2.12 6.3.2.17 6.3.2.18 6.3.2.316.3.2.32 6.3.2.33 6.3.2.34 6.3.2.416.3.2.42 6.3.2.53 6.3.2.60 6.3.2.-6.3.4.2 6.3.4.12 6.3.4.24 6.3.5.16.3.5.2 6.3.5.3 6.3.5.4 6.3.5.56.3.5.6 6.3.5.7 6.3.5.9 6.3.5.106.3.5.11 6.3.5.12 6.3.5.13 6.3.5.-,"M00015 Proline biosynthesis, glutamate => prolineM00027 GABA (gamma-Aminobutyrate) shuntM00028 Ornithine biosynthesis, glutamate => ornithineM00045 Histidine degradation, histidine => N-formiminoglutamate => glutamateM00118 Glutathione biosynthesis, glutamate => glutathioneM00121 Heme biosynthesis, plants and bacteria, glutamate => hemeM00532 PhotorespirationM00740 Methylaspartate cycleM00763 Ornithine biosynthesis, mediated by LysW, glutamate => ornithineM00845 Arginine biosynthesis, glutamate => acetylcitrulline => arginineM00879 Arginine succinyltransferase pathway, arginine => glutamate",,,,
C00158 Compound,"Citrate;Citric acid;2-Hydroxy-1,2,3-propanetricarboxylic acid;2-Hydroxytricarballylic acid",,C6H8O7,192.027,192.1235,,Same as: D00037,,,"Compounds with biological roles [BR:br08001]Organic acidsCarboxylic acidsTricarboxylic acidsC00158 CitrateAnatomical Therapeutic Chemical (ATC) classification [BR:br08303]A ALIMENTARY TRACT AND METABOLISMA09 DIGESTIVES, INCL. ENZYMESA09A DIGESTIVES, INCL. ENZYMESA09AB Acid preparationsA09AB04 Citric acidD00037 Citric acid, anhydrous (USP)Risk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsInorganic and organic chemicalsAnhydrous citric acidD00037 Citric acid, anhydrous (USP)Drugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD00037 Anhydrous citric acid",CAS: 77-92-9PubChem: 3458ChEBI: 16947 30769KNApSAcK: C00007619PDB-CCD: CIT FLC3DMET: B00046NIKKAJI: J2.824J,131 O6a O 14.3500 -22.68002 C6a C 15.5624 -21.98003 C1b C 16.7749 -22.68004 C1d C 17.9873 -21.98005 C1b C 19.1997 -22.68006 C6a C 20.4122 -21.98007 O6a O 21.6246 -22.68008 O6a O 15.5624 -20.58029 O6a O 20.4122 -20.720310 C6a C 17.9873 -20.580011 O6a O 19.2018 -19.738812 O6a O 16.7769 -19.741213 O1a O 18.3497 -23.6123,121 1 2 12 2 3 13 3 4 14 4 5 15 5 6 16 6 7 17 2 8 28 6 9 29 4 10 110 10 11 111 10 12 212 4 13 1,,,R00351 R00352 R00362 R01322 R01323 R01324 R01325 R10090R10677 R12308 R12353 R12354 R12596,"map00020 Citrate cycle (TCA cycle)map00250 Alanine, aspartate and glutamate metabolismmap00630 Glyoxylate and dicarboxylate metabolismmap00720 Carbon fixation pathways in prokaryotesmap01053 Biosynthesis of siderophore group nonribosomal peptidesmap01060 Biosynthesis of plant secondary metabolitesmap01061 Biosynthesis of phenylpropanoidsmap01062 Biosynthesis of terpenoids and steroidsmap01063 Biosynthesis of alkaloids derived from shikimate pathwaymap01064 Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acidmap01065 Biosynthesis of alkaloids derived from histidine and purinemap01066 Biosynthesis of alkaloids derived from terpenoid and polyketidemap01070 Biosynthesis of plant hormonesmap01100 Metabolic pathwaysmap01110 Biosynthesis of secondary metabolitesmap01120 Microbial metabolism in diverse environmentsmap01200 Carbon metabolismmap01210 2-Oxocarboxylic acid metabolismmap01230 Biosynthesis of amino acidsmap01240 Biosynthesis of cofactorsmap02020 Two-component systemmap04742 Taste transductionmap04922 Glucagon signaling pathwaymap05230 Central carbon metabolism in cancer",2.3.3.1 2.3.3.3 2.3.3.8 2.3.3.162.8.3.10 4.1.3.6 4.2.1.3 6.2.1.186.3.1.17 6.3.2.38 6.3.2.54 6.3.2.576.3.2.58 6.3.2.-,"M00009 Citrate cycle (TCA cycle, Krebs cycle)M00010 Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarateM00012 Glyoxylate cycleM00173 Reductive citrate cycle (Arnon-Buchanan cycle)M00740 Methylaspartate cycle",,,,
C00072 Compound,Ascorbate;Ascorbic acid;L-Ascorbate;L-Ascorbic acid;Vitamin C,,C6H8O6,176.0321,176.1241,,Same as: D00018,,,"Compounds with biological roles [BR:br08001]Vitamins and cofactorsVitaminsWater-soluble vitaminsC00072 Ascorbic acid (Vitamin C)Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]A ALIMENTARY TRACT AND METABOLISMA11 VITAMINSA11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONSA11GA Ascorbic acid (vitamin C), plainA11GA01 Ascorbic acid (vit C)D00018 Ascorbic acid (JP18/USP/INN) &lt;JP/US&gt;G GENITO URINARY SYSTEM AND SEX HORMONESG01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICSG01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDSG01AD Organic acidsG01AD03 Ascorbic acidD00018 Ascorbic acid (JP18/USP/INN) &lt;JP/US&gt;S SENSORY ORGANSS01 OPHTHALMOLOGICALSS01X OTHER OPHTHALMOLOGICALSS01XA Other ophthalmologicalsS01XA15 Ascorbic acidD00018 Ascorbic acid (JP18/USP/INN) &lt;JP/US&gt;Therapeutic category of drugs in Japan [BR:br08301]3 Agents affecting metabolism31 Vitamins314 Vitamin C preparations3140 Vitamin C preparationsD00018 Ascorbic acid (JP18/USP/INN)Classification of Japanese OTC drugs [BR:br08313]Nourishing tonics and health supplements38 Vitamin C based drugsD00018 Ascorbic acid (JP18/USP/INN)41 Vitamin EC based drugsD00018 Ascorbic acid (JP18/USP/INN)43 Vitamin containing supplementsD00018 Ascorbic acid (JP18/USP/INN)Risk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsInorganic and organic chemicalsAscorbic acidD00018 Ascorbic acid (JP18/USP/INN)Animal drugs in Japan [BR:br08331]96 Agents affecting metabolism962 Vitamin preparations9624 Vitamin C and preparationsC00072 AscorbateDrugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD00018 Ascorbic acidD00018 Ascorbic acid powderD00018 Ascorbic acid injection",CAS: 50-81-7PubChem: 3372ChEBI: 29073 38290KNApSAcK: C00001179PDB-CCD: ASC3DMET: B01147NIKKAJI: J2.301I,121 C1y C 28.9431 -22.06762 C2y C 29.3912 -23.38883 O7x O 30.0780 -21.25264 C2y C 30.7940 -23.38885 C7x C 31.2131 -22.08506 O1a O 31.6263 -24.51817 O6a O 32.1968 -21.08978 C1c C 27.7354 -21.37049 C1b C 26.5276 -22.067610 O1a O 28.5753 -24.527411 O1a O 27.7351 -19.959112 O1a O 25.2940 -21.3555,121 1 2 12 1 3 13 2 4 24 3 5 15 4 6 16 5 7 27 4 5 18 1 8 19 8 9 110 2 10 111 8 11 1 #Down12 9 12 1,,,R00068 R00095 R00640 R00643 R00644 R00645 R00646 R00647R01108 R02535 R03147 R03186 R03912 R07178 R07179 R07214R07671 R07679 R08358 R09540 R09739 R10053 R10055,map00053 Ascorbate and aldarate metabolismmap00480 Glutathione metabolismmap01100 Metabolic pathwaysmap01110 Biosynthesis of secondary metabolitesmap01120 Microbial metabolism in diverse environmentsmap01240 Biosynthesis of cofactorsmap02060 Phosphotransferase system (PTS)map04066 HIF-1 signaling pathwaymap04977 Vitamin digestion and absorption,1.1.3.8 1.3.2.3 1.3.3.12 1.6.5.41.8.5.1 1.10.3.3 1.11.1.11 1.14.17.11.14.17.3 1.14.17.4 1.14.-.- 1.23.5.12.7.1.194 7.2.1.3,"M00114 Ascorbate biosynthesis, plants, fructose-6P => ascorbateM00129 Ascorbate biosynthesis, animals, glucose-1P => ascorbateM00550 Ascorbate degradation, ascorbate => D-xylulose-5P",,,,
C00180 Compound,Benzoate;Benzoic acid;Benzenecarboxylic acid;Phenylformic acid;Dracylic acid,,C7H6O2,122.0368,122.1213,,Same as: D00038,,,Therapeutic category of drugs in Japan [BR:br08301]7 Agents not mainly for therapeutic purpose73 Public health agents731 Antiseptics7319 OthersD00038 Benzoic acid (JP18/USP)Risk category of Japanese OTC drugs [BR:br08312]Designated second-class OTC drugsInorganic and organic chemicalsBenzoic acidD00038 Benzoic acid (JP18/USP)Second-class OTC drugsInorganic and organic chemicalsBenzoic acidD00038 Benzoic acid (JP18/USP)Third-class OTC drugsInorganic and organic chemicalsBenzoic acidD00038 Benzoic acid (JP18/USP)Animal drugs in Japan [BR:br08331]99 Agents for not mainly purpose of therapeutic992 Amphoteric soap and preparations9929 Other agents for disinfectionsC00180 BenzoateDrugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD00038 Benzoic acid,CAS: 65-85-0PubChem: 3480ChEBI: 16150 30746KNApSAcK: C00000207PDB-CCD: BEZ3DMET: B00053NIKKAJI: J2.358B,91 C8y C 21.2100 -16.97632 C8x C 20.0003 -17.66763 C8x C 22.4262 -17.66764 C6a C 21.2037 -15.58095 C8x C 20.0003 -19.07596 C8x C 22.4262 -19.07597 O6a O 22.4069 -14.88328 O6a O 19.9938 -14.88979 C8x C 21.2100 -19.7863,91 1 2 22 1 3 13 1 4 14 2 5 15 3 6 26 4 7 17 4 8 28 5 9 29 6 9 1,,,R01295 R01419 R01420 R01421 R01422 R01423 R01424 R01425R01426 R01427 R02606 R05590 R05591 R05621 R05622 R06727R06728 R07188 R07835 R08838 R09088 R10447,map00362 Benzoate degradationmap00621 Dioxin degradationmap00623 Toluene degradationmap00627 Aminobenzoate degradationmap00996 Biosynthesis of various alkaloidsmap01063 Biosynthesis of alkaloids derived from shikimate pathwaymap01100 Metabolic pathwaysmap01110 Biosynthesis of secondary metabolitesmap01120 Microbial metabolism in diverse environmentsmap01220 Degradation of aromatic compounds,1.2.1.7 1.2.1.28 1.14.12.10 1.14.13.-1.14.14.92 2.1.1.273 3.1.1.1 3.1.1.843.5.1.4 3.5.1.32 3.5.1.40 3.5.5.13.6.1.7 3.6.1.20 3.7.1.8 6.2.1.25,"M00538 Toluene degradation, toluene => benzoateM00543 Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoateM00551 Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol",,,,
C00714 Compound,"Pectin;Poly(1,4-alpha-D-galacturonide)",,(C26H36O24)n,,,,Same as: D02316 G10591,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]A ALIMENTARY TRACT AND METABOLISMA07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTSA07B INTESTINAL ADSORBENTSA07BC Other intestinal adsorbentsA07BC01 PectinD02316 Pectin (USP)Risk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsCrude drugsPectinD02316 Pectin (USP)",CAS: 9000-69-5PubChem: 3980ChEBI: 17309NIKKAJI: J203.740H,521 C1y C 24.7226 -16.79722 C1y C 24.7226 -15.64603 O2a O 22.5294 -17.94144 C1y C 25.7170 -17.37625 O2x O 25.7170 -15.07406 C7a C 23.7214 -15.07407 C1y C 20.0718 -17.06288 C1y C 26.7114 -16.79729 O1a O 25.7170 -18.520510 C1y C 26.7114 -15.646011 O7a O 23.7501 -13.916212 O6a O 22.7268 -15.646013 O2x O 19.0637 -17.634814 C1y C 20.0718 -15.911715 O1a O 27.5968 -17.580416 O2a O 28.7712 -14.869617 C1y C 18.0624 -17.062818 C1y C 19.0637 -15.332819 O1a O 21.0662 -15.332820 C1y C 30.8200 -15.591521 C1y C 18.0624 -15.911722 C6a C 17.0818 -17.634823 O1a O 19.0637 -14.181624 C1y C 30.8200 -16.749425 C1y C 31.8212 -15.019526 O2a O 15.9919 -14.958127 O6a O 16.2032 -16.762228 O2x O 31.8212 -17.328329 C6a C 29.8257 -17.328330 C1y C 32.8089 -15.605231 O1a O 31.8212 -13.882032 C1y C 13.9416 -15.972933 C1y C 32.8089 -16.749434 O6a O 28.9401 -16.455635 O1a O 33.8102 -15.019536 O2x O 12.9334 -15.394037 C1y C 13.9416 -17.124038 O1a O 34.1506 -17.542739 C1y C 11.9321 -15.972940 C1y C 12.9334 -17.703141 O1a O 14.9905 -17.907542 C1x C 11.9321 -17.124043 C7a C 10.9378 -15.394044 O1a O 12.9334 -18.840545 Z * 8.0140 -18.298746 O7a O 10.9378 -14.243047 O6a O 9.9433 -15.972948 C1a C 24.8844 -13.298749 O6a O 29.8257 -18.636650 O6a O 17.0818 -18.943151 C1a C 12.0491 -13.601852 Z * 35.9229 -17.0404,551 1 2 12 1 3 1 #Up3 1 4 14 2 5 15 2 6 1 #Up6 7 3 1 #Up7 4 8 18 4 9 1 #Up9 5 10 110 6 11 111 6 12 212 7 13 113 7 14 114 8 15 1 #Down15 10 16 1 #Down16 13 17 117 14 18 118 14 19 1 #Up19 20 16 1 #Down20 17 21 121 17 22 1 #Down22 18 23 1 #Down23 20 24 124 20 25 125 21 26 1 #Down26 22 27 127 24 28 128 24 29 1 #Down29 25 30 130 25 31 1 #Down31 32 26 1 #Down32 28 33 133 29 34 134 30 35 1 #Up35 32 36 136 32 37 137 33 38 1 #Up38 36 39 139 37 40 140 37 41 1 #Down41 39 42 142 39 43 1 #Up43 40 44 1 #Up44 42 45 1 #Up45 43 46 146 43 47 247 8 10 148 18 21 149 30 33 150 40 42 151 11 48 152 29 49 253 22 50 254 46 51 155 38 52 1,,,R02362 R05191,map00040 Pentose and glucuronate interconversionsmap00520 Amino sugar and nucleotide sugar metabolismmap01100 Metabolic pathwaysmap04973 Carbohydrate digestion and absorption,2.4.1.43 3.1.1.11,M00081 Pectin degradation,1 9.2400 -19.4600 9.2400 -12.95001 34.8600 -12.9500 34.8600 -19.46001 nORIGINAL 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 161 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 321 33 34 35 36 37 38 39 40 41 42 43 44 46 47 48 491 50 51REPEAT 1,,,
C08822 Compound,Gum arabic,,,,,,,,,,CAS: 9000-01-5PubChem: 11015NIKKAJI: J2.523.247J J203.711D,,,,,,map04973 Carbohydrate digestion and absorption,,,,,,
C01935 Compound,Maltodextrin;Maltodextrin(n);Maltodextrin(n-2);n+2 Maltodextrin;Linear maltodextrin;Maltooligosaccharide,,H2O(C6H10O5)n,,,,Same as: D02329 G10495,,,,CAS: 9050-36-6PubChem: 5040ChEBI: 18398,341 C1y C 12.3200 -18.13002 C1y C 12.3200 -19.53003 C1y C 13.5324 -20.23004 C1y C 14.7449 -19.53005 C1y C 14.7449 -18.13006 O2x O 13.5324 -17.43007 C1b C 11.1076 -17.43008 O2a O 15.9760 -17.41909 O1a O 13.5324 -21.629810 C1y C 18.0284 -16.159011 C1y C 19.2692 -16.875512 C1y C 20.4817 -16.175713 C1y C 20.4819 -14.775714 O2x O 19.2411 -14.059115 C1y C 18.0286 -14.759016 O2a O 21.7179 -14.062117 C1y C 23.7003 -12.802118 C1y C 24.9383 -13.517119 C1y C 26.1508 -12.817320 C1y C 26.1510 -11.417321 O2x O 24.9130 -10.702322 C1y C 23.7005 -11.402123 O1a O 19.2690 -18.269924 C1b C 16.8446 -14.075125 C1b C 22.5138 -10.716626 O1a O 24.9380 -14.909927 O1a O 27.3883 -10.702928 O1a O 27.3816 -13.528429 O1a O 21.7125 -16.886930 O1a O 15.9760 -20.241031 O1a O 11.1076 -20.230032 O1a O 9.9121 -18.120433 O1a O 15.6534 -14.762734 O1a O 21.3238 -11.4034,361 1 2 12 2 3 13 3 4 14 4 5 15 5 6 16 1 6 17 1 7 1 #Up8 5 8 1 #Down9 3 9 1 #Up10 10 8 1 #Down11 10 11 112 11 12 113 12 13 114 13 14 115 14 15 116 10 15 117 13 16 1 #Down18 17 16 1 #Down19 17 18 120 18 19 121 19 20 122 20 21 123 21 22 124 17 22 125 11 23 1 #Up26 15 24 1 #Up27 22 25 1 #Up28 18 26 1 #Up29 20 27 1 #Either30 19 28 1 #Down31 12 29 1 #Down32 4 30 1 #Down33 2 31 1 #Down34 7 32 135 24 33 136 25 34 1,,,R01824 R03122 R11256 R11261 R11262,map00500 Starch and sucrose metabolismmap01100 Metabolic pathwaysmap01110 Biosynthesis of secondary metabolitesmap02010 ABC transporters,3.2.1.1 3.2.1.2 3.2.1.54 3.2.1.683.2.1.133 3.2.1.141 5.4.99.15,"M00565 Trehalose biosynthesis, D-glucose 1P => trehalose",1 17.4300 -17.6400 17.4300 -15.82001 22.0500 -12.8100 22.0500 -14.63001 n-2ORIGINAL 1 10 11 12 13 14 15 16 23 24 29 33REPEAT 1,,,
C12285 Compound,Sucralose,,C12H19Cl3O8,396.0146,397.6335,,,,,,CAS: 56038-13-2PubChem: 14429ChEBI: 32159PDB-CCD: 40JNIKKAJI: J247.962A,231 C1z C 25.2426 -20.61262 C1y C 25.6008 -21.95833 C1y C 26.9919 -21.96844 C1y C 27.4887 -20.73775 O2x O 26.4122 -19.85826 C1y C 20.3397 -19.19987 C1y C 20.4028 -20.60148 C1y C 21.6141 -21.31209 C1y C 22.8325 -20.613610 O2x O 22.8396 -19.211911 C1y C 21.6283 -18.508512 O2a O 24.0440 -21.324213 O1a O 21.6071 -22.713814 O1a O 19.1843 -21.299815 X Cl 19.1984 -18.496316 C1b C 21.6352 -17.106617 C1b C 24.8977 -19.261318 O1a O 27.7582 -23.208319 C1b C 28.8431 -20.370020 O1a O 24.7158 -23.049121 X Cl 29.2079 -19.009622 X Cl 25.5871 -18.037523 O1a O 22.8536 -16.4084,241 9 12 1 #Down2 1 12 1 #Down3 1 2 14 8 13 1 #Down5 2 3 16 7 14 1 #Up7 3 4 18 6 15 1 #Up9 4 5 110 11 16 1 #Up11 5 1 112 1 17 1 #Up13 6 7 114 3 18 1 #Up15 7 8 116 4 19 1 #Down17 8 9 118 2 20 1 #Down19 9 10 120 19 21 121 10 11 122 17 22 123 11 6 124 16 23 1,,,,map04973 Carbohydrate digestion and absorption,,,,,,
C11045 Compound,Aspartame,,C14H18N2O5,294.1216,294.3031,,Same as: D02381,,,Target-based classification of drugs [BR:br08310]G Protein-coupled receptorsMetabotropic glutamate receptor familyChemoreceptionTAS1R2D02381 Aspartame (NF/INN)TAS1R3D02381 Aspartame (NF/INN),CAS: 22839-47-0PubChem: 13228ChEBI: 177838 2877PDB-CCD: PMENIKKAJI: J11.477D,211 C8y C 21.6273 -15.08632 C8x C 22.8405 -15.79163 C8x C 24.0556 -15.08924 C8x C 24.0573 -13.68825 C8x C 22.8439 -12.98996 C8x C 21.6290 -13.68547 O6a O 13.1411 -17.20958 C6a C 14.3543 -17.90109 C1b C 15.5676 -17.202610 C1c C 16.7810 -17.893911 C5a C 17.9873 -17.195512 N1b N 19.2005 -17.886713 C1c C 20.4139 -17.188414 C7a C 21.6273 -17.879815 O7a O 22.8405 -17.181416 C1a C 24.0539 -17.872717 O6a O 14.3473 -19.304618 N1a N 16.7739 -19.297719 O5a O 17.9802 -15.791620 O6a O 21.6202 -19.283521 C1b C 20.4139 -15.7916,211 10 11 12 5 6 23 11 12 14 6 1 15 12 13 16 13 14 17 1 2 28 14 15 19 7 8 110 15 16 111 2 3 112 8 17 213 8 9 114 10 18 1 #Up15 3 4 216 11 19 217 9 10 118 14 20 219 4 5 120 13 21 1 #Up21 21 1 1,,,,map04742 Taste transduction,,,,,,
C09189 Compound,Stevioside,,C38H60O18,804.378,804.8722,,,,,Lipids [BR:br08002]PR Prenol lipidsPR01 IsoprenoidsPR0104 C20 isoprenoids (diterpenes)PR010413 Kaurane and phyllocladane diterpenoidsC09189 SteviosidePhytochemical compounds [BR:br08003]TerpenoidsDiterpenoids (C20)KaurenesC09189 Stevioside,CAS: 57817-89-7PubChem: 11381ChEBI: 9271LIPIDMAPS: LMPR01040119KNApSAcK: C000034853DMET: B02755NIKKAJI: J27.441K,561 O7a O 26.3804 -23.13582 C1y C 25.1797 -23.84193 O2x O 23.9774 -23.16874 C1y C 25.2071 -25.22855 C1y C 22.7931 -23.86256 C1y C 24.0078 -25.92067 O1a O 26.4145 -25.90458 C1y C 22.8024 -25.25259 C1b C 21.5857 -23.186510 O1a O 24.0259 -27.309111 O1a O 21.6108 -25.957112 O1a O 20.4032 -23.895913 C1z C 30.1018 -18.505814 C1y C 28.9267 -17.798015 C1x C 31.3074 -17.822716 C1x C 30.1018 -19.883817 C1z C 27.7213 -18.494118 C1x C 28.9324 -16.420019 C1z C 31.2560 -16.444520 C1x C 28.9150 -20.565721 C1y C 27.7096 -19.878122 C1x C 26.5216 -17.792323 C1a C 27.7096 -17.110224 C1x C 30.1322 -15.744025 O2a O 31.3141 -15.024226 C1z C 26.5225 -20.565427 C1x C 25.3149 -18.494128 C1y C 32.5655 -14.214829 C1x C 25.3149 -19.878130 C1y C 32.5712 -12.836731 O2x O 33.7722 -14.909732 O2a O 31.3775 -12.141833 C1y C 33.7722 -12.153534 C1y C 34.9650 -14.226435 C1y C 31.3658 -10.758036 C1y C 34.9650 -12.836737 O1a O 33.7839 -10.763938 C1b C 36.1644 -14.921339 O2x O 32.5469 -10.057440 C1y C 30.1604 -10.076141 O1a O 36.1644 -12.153542 O1a O 37.3584 -14.239343 C1y C 32.5410 -8.673644 C1y C 30.1545 -8.692245 O1a O 28.9606 -10.775646 C1y C 31.3356 -7.997647 C1b C 33.7477 -7.991748 O1a O 28.9490 -8.031749 O1a O 31.3297 -6.625050 C1x C 31.2920 -19.188951 C2y C 32.5167 -17.140852 C2a C 33.8589 -16.792153 C1a C 26.9214 -21.969154 C7a C 25.8204 -21.790455 O6a O 24.4269 -21.794956 O1a O 33.7606 -6.5983,621 2 1 1 #Up2 2 3 13 2 4 14 3 5 15 4 6 16 4 7 1 #Down7 5 8 18 5 9 1 #Up9 6 10 1 #Up10 8 11 1 #Down11 13 14 112 13 15 113 13 16 114 14 17 115 14 18 116 15 19 117 16 20 118 17 21 119 17 22 120 17 23 1 #Down21 18 24 122 19 25 1 #Down23 21 26 124 22 27 125 28 25 1 #Up26 26 29 127 28 30 128 28 31 129 30 32 1 #Down30 30 33 131 31 34 132 35 32 1 #Up33 33 36 134 33 37 1 #Up35 34 38 1 #Up36 35 39 137 35 40 138 36 41 1 #Down39 38 42 140 39 43 141 40 44 142 40 45 1 #Down43 43 46 144 43 47 1 #Up45 44 48 1 #Up46 46 49 1 #Down47 19 24 148 20 21 149 27 29 150 34 36 151 44 46 152 13 50 1 #Up53 19 51 1 #Up54 50 51 155 51 52 256 26 53 1 #Up57 26 54 1 #Down58 54 1 159 9 12 160 54 55 261 6 8 162 47 56 1,,,R08401,map00904 Diterpenoid biosynthesismap01062 Biosynthesis of terpenoids and steroidsmap01110 Biosynthesis of secondary metabolites,,,,,,
C00009 Compound,Orthophosphate;Phosphate;Phosphoric acid;Orthophosphoric acid,,H3PO4,97.9769,97.9952,,Same as: D05467,,,,CAS: 7664-38-2PubChem: 3311ChEBI: 18367 26078KNApSAcK: C00007408PDB-CCD: 2HP PI PO43DMET: B00002NIKKAJI: J3.746J,51 P1b P 27.1282 -21.25722 O1c O 25.9971 -21.90113 O1c O 28.4489 -21.83604 O1c O 27.4637 -22.77285 O1c O 27.1282 -19.9529,41 1 2 12 1 3 13 1 4 14 1 5 2,,,R00002 R00004 R00077 R00085 R00086 R00118 R00122 R00126R00128 R00129 R00138 R00149 R00155 R00159 R00164 R00173R00177 R00183 R00188 R00199 R00206 R00207 R00208 R00229R00230 R00251 R00253 R00283 R00303 R00304 R00317 R00318R00320 R00328 R00329 R00335 R00344 R00345 R00346 R00352R00394 R00405 R00425 R00432 R00437 R00438 R00439 R00440R00482 R00497 R00508 R00511 R00514 R00530 R00539 R00548R00569 R00571 R00573 R00575 R00582 R00584 R00615 R00618R00626 R00660 R00719 R00723 R00727 R00742 R00747 R00748R00761 R00762 R00763 R00764 R00774 R00803 R00804 R00805R00841 R00872 R00883 R00894 R00910 R00912 R00920 R00921R00942 R00943 R00947 R00952 R00953 R00957 R00961 R00963R00993 R01003 R01004 R01010 R01016 R01043 R01044 R01052R01053 R01061 R01063 R01121 R01126 R01135 R01150 R01164R01174 R01185 R01186 R01187 R01227 R01256 R01322 R01334R01396 R01397 R01398 R01399 R01402 R01421 R01466 R01511R01515 R01555 R01561 R01562 R01569 R01570 R01585 R01620R01621 R01654 R01664 R01667 R01714 R01724 R01748 R01788R01804 R01805 R01821 R01826 R01845 R01859 R01863 R01876R01877 R01882 R01911 R01917 R01968 R01969 R01991 R02029R02073 R02088 R02092 R02095 R02102 R02111 R02135 R02147R02148 R02167 R02228 R02237 R02238 R02239 R02248 R02249R02291 R02294 R02295 R02296 R02297 R02298 R02301 R02319R02323 R02330 R02370 R02402 R02404 R02405 R02406 R02451R02484 R02494 R02557 R02585 R02587 R02597 R02646 R02706R02719 R02727 R02730 R02731 R02741 R02748 R02751 R02769R02778 R02783 R02786 R02788 R02853 R02866 R02885 R02888R02929 R02937 R03013 R03024 R03042 R03060 R03083 R03095R03116 R03142 R03143 R03151 R03157 R03182 R03187 R03193R03254 R03273 R03286 R03298 R03313 R03330 R03346 R03350R03363 R03371 R03372 R03393 R03394 R03409 R03427 R03430R03434 R03443 R03450 R03454 R03460 R03474 R03494 R03496R03515 R03595 R03699 R03822 R03877 R03905 R03969 R03993R04068 R04138 R04144 R04156 R04162 R04167 R04208 R04212R04241 R04248 R04281 R04292 R04312 R04317 R04369 R04372R04385 R04404 R04435 R04457 R04463 R04479 R04513 R04542R04573 R04591 R04594 R04617 R04620 R04621 R04730 R04771R04780 R04944 R05030 R05086 R05185 R05186 R05197 R05224R05225 R05227 R05230 R05326 R05453 R05465 R05496 R05512R05603 R05625 R05627 R05647 R05651 R05735 R05746 R05767R05777 R05779 R05789 R05790 R05791 R05815 R05838 R06018R06022 R06034 R06040 R06044 R06050 R06053 R06056 R06057R06058 R06061 R06185 R06211 R06228 R06282 R06367 R06396R06520 R06521 R06522 R06529 R06591 R06592 R06772 R06870R06871 R06875 R06974 R06975 R07226 R07227 R07228 R07245R07264 R07265 R07274 R07280 R07282 R07285 R07297 R07298R07299 R07302 R07306 R07343 R07383 R07394 R07395 R07404R07414 R07420 R07456 R07582 R07583 R07584 R07641 R07642R07674 R07828 R08061 R08062 R08063 R08064 R08069 R08070R08071 R08079 R08144 R08200 R08201 R08219 R08222 R08224R08229 R08230 R08323 R08352 R08353 R08354 R08355 R08368R08515 R08548 R08577 R08617 R08650 R08658 R08855 R08887R08899 R08905 R08906 R08924 R08937 R08981 R08982 R09053R09060 R09399 R09400 R09401 R09530 R09532 R09588 R09590R09592 R09593 R09594 R09595 R09596 R09598 R09599 R09632R09644 R09664 R09668 R09752 R09760 R09771 R09775 R09777R09827 R09841 R09853 R09858 R09877 R09941 R09942 R09943R09978 R09994 R10088 R10089 R10098 R10235 R10244 R10267R10268 R10270 R10288 R10304 R10442 R10443 R10469 R10470R10486 R10496 R10531 R10541 R10546 R10547 R10561 R10610R10622 R10677 R10678 R10679 R10693 R10722 R10748 R10758R10767 R10768 R10772 R10776 R10781 R10811 R10814 R10821R10822 R10829 R10832 R10836 R10837 R10838 R10892 R10901R10902 R10928 R10929 R10931 R10935 R10937 R10941 R10942R10943 R10944 R10949 R10950 R10973 R10987 R10993 R10994R11053 R11064 R11085 R11095 R11127 R11128 R11140 R11173R11180 R11188 R11207 R11225 R11240 R11251 R11258 R11259R11279 R11281 R11326 R11327 R11397 R11398 R11439 R11440R11527 R11531 R11551 R11552 R11627 R11628 R11629 R11662R11673 R11680 R11705 R11785 R11919 R11941 R11959 R11964R12084 R12092 R12114 R12124 R12125 R12150 R12151 R12201R12203 R12240 R12241 R12243 R12272 R12331 R12352 R12451R12531 R12532 R12533 R12565 R12567 R12580 R12583 R12587R12589 R12595 R12614 R12661 R12700 R12703 R12786 R12896R12934 R12945 R12958 R12979 R13002,"map00190 Oxidative phosphorylationmap00195 Photosynthesismap02010 ABC transportersmap02020 Two-component systemmap02024 Quorum sensingmap04111 Cell cycle - yeastmap04928 Parathyroid hormone synthesis, secretion and actionmap04978 Mineral absorptionmap05012 Parkinson diseasemap05022 Pathways of neurodegeneration - multiple diseases",1.2.1.11 1.2.1.12 1.2.1.13 1.2.1.381.2.1.41 1.2.1.59 1.2.1.103 1.2.1.1061.2.1.- 1.2.3.3 1.2.3.- 1.3.7.71.3.7.8 1.3.7.14 1.3.7.15 1.13.11.781.13.11.89 1.13.11.90 1.14.11.49 1.18.6.11.18.6.2 1.19.6.1 1.20.1.1 1.21.4.21.21.4.3 1.21.4.4 2.1.3.2 2.1.3.32.1.3.5 2.1.3.6 2.1.3.7 2.1.3.82.1.3.9 2.1.3.11 2.1.3.12 2.1.3.162.1.3.- 2.3.1.8 2.3.1.19 2.3.1.322.3.1.222 2.3.1.274 2.3.1.275 2.3.3.82.3.3.15 2.4.1.1 2.4.1.7 2.4.1.82.4.1.20 2.4.1.30 2.4.1.31 2.4.1.492.4.1.64 2.4.1.97 2.4.1.139 2.4.1.2112.4.1.216 2.4.1.230 2.4.1.231 2.4.1.2472.4.1.279 2.4.1.280 2.4.1.281 2.4.1.2822.4.1.319 2.4.1.320 2.4.1.321 2.4.1.3292.4.1.332 2.4.1.333 2.4.1.334 2.4.1.3392.4.1.340 2.4.1.352 2.4.1.359 2.4.1.3882.4.1.389 2.4.2.1 2.4.2.2 2.4.2.32.4.2.4 2.4.2.15 2.4.2.16 2.4.2.282.4.2.44 2.4.2.57 2.4.99.16 2.5.1.62.5.1.7 2.5.1.19 2.5.1.47 2.5.1.482.5.1.54 2.5.1.55 2.5.1.56 2.5.1.572.5.1.65 2.5.1.66 2.5.1.72 2.5.1.732.5.1.76 2.5.1.78 2.5.1.95 2.5.1.972.5.1.101 2.5.1.113 2.5.1.129 2.5.1.1322.5.1.140 2.5.1.154 2.5.1.- 2.6.99.22.7.1.79 2.7.1.80 2.7.1.90 2.7.1.1432.7.1.238 2.7.2.12 2.7.3.13 2.7.7.52.7.7.8 2.7.7.22 2.7.7.35 2.7.7.362.7.7.37 2.7.7.53 2.7.7.56 2.7.7.782.7.7.89 2.7.9.1 2.7.9.2 2.7.9.32.7.9.6 2.7.99.1 2.8.5.1 2.9.1.12.9.1.2 2.9.1.3 3.1.3.1 3.1.3.23.1.3.3 3.1.3.4 3.1.3.5 3.1.3.63.1.3.7 3.1.3.8 3.1.3.9 3.1.3.103.1.3.11 3.1.3.12 3.1.3.14 3.1.3.153.1.3.16 3.1.3.17 3.1.3.18 3.1.3.193.1.3.20 3.1.3.21 3.1.3.22 3.1.3.233.1.3.24 3.1.3.25 3.1.3.26 3.1.3.273.1.3.28 3.1.3.29 3.1.3.32 3.1.3.333.1.3.34 3.1.3.35 3.1.3.36 3.1.3.373.1.3.38 3.1.3.39 3.1.3.40 3.1.3.413.1.3.42 3.1.3.43 3.1.3.44 3.1.3.453.1.3.46 3.1.3.47 3.1.3.48 3.1.3.493.1.3.50 3.1.3.51 3.1.3.52 3.1.3.533.1.3.54 3.1.3.55 3.1.3.56 3.1.3.573.1.3.58 3.1.3.59 3.1.3.60 3.1.3.623.1.3.63 3.1.3.64 3.1.3.66 3.1.3.673.1.3.68 3.1.3.69 3.1.3.70 3.1.3.713.1.3.72 3.1.3.73 3.1.3.74 3.1.3.753.1.3.76 3.1.3.77 3.1.3.78 3.1.3.793.1.3.80 3.1.3.82 3.1.3.83 3.1.3.853.1.3.86 3.1.3.87 3.1.3.88 3.1.3.893.1.3.90 3.1.3.91 3.1.3.92 3.1.3.933.1.3.94 3.1.3.95 3.1.3.96 3.1.3.973.1.3.99 3.1.3.100 3.1.3.101 3.1.3.1023.1.3.103 3.1.3.104 3.1.3.105 3.1.3.1063.1.3.107 3.1.3.108 3.1.3.- 3.1.4.573.2.1.23 3.5.2.9 3.5.2.14 3.5.4.253.5.4.29 3.6.1.1 3.6.1.5 3.6.1.63.6.1.7 3.6.1.8 3.6.1.11 3.6.1.123.6.1.14 3.6.1.15 3.6.1.25 3.6.1.273.6.1.28 3.6.1.39 3.6.1.40 3.6.1.423.6.1.43 3.6.1.52 3.6.1.58 3.6.1.643.6.1.68 3.6.1.69 3.6.1.73 3.6.1.753.6.1.- 3.6.5.1 3.6.5.2 3.6.5.33.6.5.4 3.6.5.5 3.6.5.6 3.9.1.13.9.1.2 3.9.1.3 3.11.1.1 3.11.1.23.11.1.3 4.1.1.31 4.1.1.33 4.1.1.384.1.1.99 4.1.1.110 4.1.1.123 4.1.2.94.1.2.22 4.1.99.20 4.1.99.23 4.1.99.244.1.99.25 4.2.1.93 4.2.1.136 4.2.3.14.2.3.2 4.2.3.3 4.2.3.4 4.2.3.54.2.3.124 4.2.3.134 4.2.3.152 4.2.3.1534.2.3.154 4.2.3.155 4.3.3.6 4.99.1.-6.1.2.1 6.1.2.2 6.2.1.4 6.2.1.56.2.1.6 6.2.1.9 6.2.1.10 6.2.1.136.2.1.18 6.2.1.39 6.2.1.56 6.2.1.-6.3.1.2 6.3.1.4 6.3.1.6 6.3.1.86.3.1.9 6.3.1.10 6.3.1.11 6.3.1.126.3.1.17 6.3.1.18 6.3.1.19 6.3.1.216.3.2.2 6.3.2.3 6.3.2.4 6.3.2.66.3.2.7 6.3.2.8 6.3.2.9 6.3.2.106.3.2.11 6.3.2.12 6.3.2.13 6.3.2.166.3.2.17 6.3.2.18 6.3.2.20 6.3.2.236.3.2.25 6.3.2.29 6.3.2.30 6.3.2.316.3.2.32 6.3.2.33 6.3.2.34 6.3.2.356.3.2.37 6.3.2.41 6.3.2.42 6.3.2.436.3.2.44 6.3.2.45 6.3.2.47 6.3.2.486.3.2.49 6.3.2.53 6.3.2.60 6.3.2.-6.3.3.1 6.3.3.2 6.3.3.3 6.3.3.56.3.3.7 6.3.4.2 6.3.4.3 6.3.4.46.3.4.6 6.3.4.7 6.3.4.8 6.3.4.126.3.4.13 6.3.4.14 6.3.4.16 6.3.4.176.3.4.18 6.3.4.20 6.3.4.21 6.3.4.226.3.4.23 6.3.4.24 6.3.4.25 6.3.5.36.3.5.5 6.3.5.6 6.3.5.7 6.3.5.96.3.5.10 6.3.5.11 6.3.5.12 6.3.5.136.3.5.- 6.4.1.1 6.4.1.2 6.4.1.36.4.1.4 6.4.1.5 6.4.1.6 6.4.1.76.4.1.8 6.4.1.9 6.5.1.7 6.5.1.96.6.1.1 6.6.1.2 7.3.2.6,,,,,
C12603 Compound,Sodium bicarbonate;Sodium hydrogencarbonate,,NaHCO3,83.9823,84.0066,,Same as: D01203,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]B BLOOD AND BLOOD FORMING ORGANSB05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONSB05C IRRIGATING SOLUTIONSB05CB Salt solutionsB05CB04 Sodium bicarbonateD01203 Sodium bicarbonate (JP18/USP) &lt;JP/US&gt;B05X I.V. SOLUTION ADDITIVESB05XA Electrolyte solutionsB05XA02 Sodium bicarbonateD01203 Sodium bicarbonate (JP18/USP) &lt;JP/US&gt;USP drug classification [BR:br08302]Electrolytes/Minerals/Metals/VitaminsElectrolyte/Mineral ReplacementSodiumD01203 Sodium bicarbonate (JP18/USP)Therapeutic category of drugs in Japan [BR:br08301]2 Agents affecting individual organs23 Digestive organ agents234 Antacids2344 Inorganic saltsD01203 Sodium bicarbonate (JP18/USP)3 Agents affecting metabolism34 Dialysis agents341 Kidney dialysis agents3410 Kidney dialysis agentsD01203 Sodium bicarbonate (JP18/USP)39 Other agents affecting metabolism392 Antidotes3929 OthersD01203 Sodium bicarbonate (JP18/USP)Classification of Japanese OTC drugs [BR:br08313]Agents for digestive organs10 AntacidsD01203 Sodium bicarbonate (JP18/USP)Risk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsInorganic and organic chemicalsSodium bicarbonateD01203 Sodium bicarbonate (JP18/USP)Animal drugs in Japan [BR:br08331]96 Agents affecting metabolism967 Agents for liver disease and antidotes9679 Other agents for liver disease and antidotesC12603 Sodium bicarbonateDrug groups [BR:br08330]Gastrointestinal agentDG01975 Agents for peptic ulcerDG01954 AntacidD01203 Sodium bicarbonateDrugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD01203 Sodium bicarbonateD01203 Sodium bicarbonate injectionRx-to-OTC switch list in the USA [br08315.html]D01203,CAS: 144-55-8PubChem: 582993ChEBI: 32139NIKKAJI: J44.042F,51 C6a C 25.7819 -18.17862 O6a O 26.4894 -16.96503 O6a O 26.4777 -19.3909 #-4 O6a O 24.3845 -18.16575 Z Na 29.6575 -18.3272 #+,31 1 2 12 1 3 13 1 4 2,,,,,,,,,,
C00157 Compound,"Phosphatidylcholine;Lecithin;Phosphatidyl-N-trimethylethanolamine;1,2-Diacyl-sn-glycero-3-phosphocholine;Choline phosphatide;3-sn-Phosphatidylcholine",,C10H18NO8PR2,,,,,,,"Compounds with biological roles [BR:br08001]LipidsPhospholipidsGlycerophospholipidsC00157 Phosphatidylcholine; LecithinLipids [BR:br08002]GP GlycerophospholipidsGP01 GlycerophosphocholinesGP0101 DiacylglycerophosphocholinesC00157 1,2-Diacyl-sn-glycero-3-phosphocholine",CAS: 8002-43-5PubChem: 3457ChEBI: 16110 49183,221 P1b P 22.3185 -17.98002 O2b O 20.9987 -17.98003 O2b O 23.6441 -17.98004 O1c O 22.3126 -19.3173 #-5 O1c O 22.3243 -16.66026 C1b C 19.6787 -17.98007 C1b C 24.7888 -17.32608 C1c C 19.6671 -16.15229 C1b C 25.9334 -17.980010 O7a O 18.1137 -16.181311 C1b C 19.6787 -14.440912 N1d N 27.0840 -17.3260 #+13 C7a C 16.7879 -16.181314 O7a O 20.9987 -14.440915 C1a C 28.8301 -17.857416 C1a C 27.0840 -16.006217 C1a C 27.4227 -18.604818 O6a O 16.7763 -14.855519 R R 15.4681 -16.181320 C7a C 22.3185 -14.440921 O6a O 22.3126 -13.121122 R R 23.6441 -14.4409,211 1 2 12 1 3 13 1 4 14 1 5 25 2 6 16 3 7 17 6 8 18 7 9 19 8 10 110 8 11 111 9 12 112 10 13 113 11 14 114 12 15 115 12 16 116 12 17 117 13 18 218 13 19 119 14 20 120 20 21 221 20 22 1,,Generic compound in reaction hierarchy,R01309 R01310 R01312 R01313 R01314 R01315 R01316 R01317R01318 R01319 R01320 R01321 R02114 R04227 R04514 R05794R07064 R07377 R07859 R07860 R08387 R08969,map00564 Glycerophospholipid metabolismmap00590 Arachidonic acid metabolismmap00591 Linoleic acid metabolismmap00592 alpha-Linolenic acid metabolismmap01100 Metabolic pathwaysmap01110 Biosynthesis of secondary metabolitesmap04723 Retrograde endocannabinoid signalingmap05231 Choline metabolism in cancer,2.1.1.16 2.1.1.71 2.3.1.23 2.3.1.432.3.1.62 2.3.1.83 2.3.1.135 2.7.8.22.7.8.24 2.7.8.27 3.1.1.4 3.1.1.53.1.1.32 3.1.4.3 3.1.4.4,"M00090 Phosphatidylcholine (PC) biosynthesis, choline => PCM00091 Phosphatidylcholine (PC) biosynthesis, PE => PC",,,,
C01768 Compound,(Alginate)n;(Alginate)n+1;Alginate;Alginic acid,,(C6H8O6)n,,,,Same as: D02324 G00316 G07287 G07471 G08476 G10593,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]A ALIMENTARY TRACT AND METABOLISMA02 DRUGS FOR ACID RELATED DISORDERSA02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)A02BX13 Alginic acidD02324 Alginic acid (NF)Drug groups [BR:br08330]Gastrointestinal agentDG01975 Agents for peptic ulcerDG02008 Gastric mucosal protectantDG00028 Alginic acidD02324 Alginic acid,CAS: 9005-32-7PubChem: 4901ChEBI: 17548NIKKAJI: J209.118F,141 C1y C 26.2500 -20.93002 C1y C 26.2500 -22.33003 C1y C 27.4624 -23.03004 C1y C 28.6749 -22.33005 C1x C 28.6749 -20.93006 O2x O 27.4624 -20.23007 Z * 33.0373 -19.81008 C6a C 25.0376 -20.23009 O1a O 27.4624 -24.429810 O6a O 23.8421 -20.920411 O6a O 25.0375 -18.830212 O1a O 29.9060 -23.251013 O1a O 25.0376 -23.030014 Z * 21.8176 -23.1000,141 1 2 12 2 3 13 3 4 14 4 5 15 5 6 16 1 6 17 5 7 1 #Up8 1 8 1 #Either9 3 9 1 #Up10 8 10 211 8 11 112 4 12 1 #Up13 2 13 1 #Down14 13 14 1,,,R03129 R03706 R08693,map00051 Fructose and mannose metabolismmap01100 Metabolic pathways,2.4.1.33 4.2.2.3 4.2.2.11 5.1.3.37,,1 23.2400 -24.9900 23.2400 -17.85001 31.4300 -17.7100 31.4300 -24.85001 nORIGINAL 1 1 2 3 4 5 6 8 9 10 11 12 13REPEAT 1,,,
C08818 Compound,Carrageenan,,,,,,Same as: D03411,,,,CAS: 9000-07-1PubChem: 11011ChEBI: 3435NIKKAJI: J203.713K,,,,,,,,,,,,
C08815 Compound,Agar,,,,,,,,,,CAS: 9002-18-0PubChem: 11008ChEBI: 2509,,,,,,,,,,,,
C00369 Compound,Starch;Glycogen,,(C12H20O10)n,,,,Same as: D00084 D06507 G10545,,,Drugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD00084 Dextrin,CAS: 9005-25-8PubChem: 3659ChEBI: 28017NIKKAJI: J203.726B J203.727K J203.739D J203.741F,241 C1y C 33.7400 -14.49002 C1y C 33.7400 -15.89003 C1y C 34.9524 -16.59004 C1y C 36.1649 -15.89005 C1y C 36.1649 -14.49006 O2x O 34.9524 -13.79007 C1b C 32.5276 -13.79008 O1a O 34.9524 -17.98989 O1a O 37.3960 -13.779010 O1a O 37.3960 -16.601011 O2a O 32.5276 -16.590012 C1y C 31.3151 -17.290013 O2x O 30.0840 -16.579014 C1y C 28.8715 -17.278815 C1x C 28.8713 -18.678816 C1y C 30.1024 -19.389817 C1y C 31.3149 -18.690018 C1b C 27.6408 -16.567619 O1a O 30.1022 -20.790020 O1a O 32.5084 -19.379521 O1a O 26.4254 -17.268522 Z * 39.9160 -13.779023 O1a O 31.3321 -14.480424 Z * 24.2005 -20.6551,251 1 2 12 2 3 13 3 4 14 4 5 15 5 6 16 1 6 17 1 7 1 #Up8 3 8 1 #Up9 5 9 1 #Down10 4 10 1 #Down11 2 11 1 #Down12 12 11 1 #Down13 12 13 114 13 14 115 14 15 116 15 16 117 16 17 118 12 17 119 14 18 1 #Up20 16 19 1 #Up21 17 20 1 #Down22 18 21 123 9 22 124 7 23 125 15 24 1 #Down,,,R01790 R02108 R02109 R02110 R02111 R02112 R09995 R11260R11261,map00500 Starch and sucrose metabolismmap00710 Carbon fixation in photosynthetic organismsmap01100 Metabolic pathwaysmap01110 Biosynthesis of secondary metabolitesmap04910 Insulin signaling pathwaymap04931 Insulin resistancemap04973 Carbohydrate digestion and absorptionmap05415 Diabetic cardiomyopathy,1.14.99.55 2.4.1.1 2.4.1.18 2.4.1.193.2.1.1 3.2.1.2 3.2.1.3 3.2.1.333.2.1.68 3.2.1.133,"M00565 Trehalose biosynthesis, D-glucose 1P => trehaloseM00854 Glycogen biosynthesis, glucose-1P => glycogen/starchM00855 Glycogen degradation, glycogen => glucose-6P",1 25.4100 -21.2100 25.4100 -13.16001 38.6400 -13.1600 38.6400 -21.21001 nORIGINAL 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 161 17 18 19 20 21 23REPEAT 1,,,
C01424 Compound,"Gallate;Gallic acid;3,4,5-Trihydroxybenzoic acid;3,4,5-Trihydroxybenzoate;Pyrogallol-5-carboxylic acid",,C7H6O5,170.0215,170.1195,,,,,Phytochemical compounds [BR:br08003]OthersTannins and galloyl derivativesGalloyl derivativesC01424 Gallate,CAS: 149-91-7PubChem: 4609ChEBI: 16918 30778KNApSAcK: C00002647PDB-CCD: GDE3DMET: B00289NIKKAJI: J7.408J,121 C8y C 22.1200 -15.11272 C8x C 20.9090 -15.81123 C8x C 23.3375 -15.81124 C6a C 22.1137 -13.93235 C8y C 20.9090 -17.22086 C8y C 23.3375 -17.22087 O6a O 23.3182 -13.23388 O6a O 20.9025 -13.24019 C8y C 22.1200 -17.932210 O1a O 19.6978 -17.912811 O1a O 24.5485 -17.912812 O1a O 22.1137 -19.3290,121 1 2 22 1 3 13 1 4 14 2 5 15 3 6 26 4 7 17 4 8 28 5 9 29 5 10 110 6 11 111 9 12 112 6 9 1,,,R00053 R01637 R03247 R03297 R03549 R03550 R03551 R09271R09565 R12886,map00627 Aminobenzoate degradationmap00999 Biosynthesis of various plant secondary metabolitesmap01061 Biosynthesis of phenylpropanoidsmap01120 Microbial metabolism in diverse environments,1.13.11.3 1.13.11.8 1.13.11.57 2.1.1.3412.4.1.136 3.1.1.20 4.1.1.59,,,,,
C01424 Compound,"Gallate;Gallic acid;3,4,5-Trihydroxybenzoic acid;3,4,5-Trihydroxybenzoate;Pyrogallol-5-carboxylic acid",,C7H6O5,170.0215,170.1195,,,,,Phytochemical compounds [BR:br08003]OthersTannins and galloyl derivativesGalloyl derivativesC01424 Gallate,CAS: 149-91-7PubChem: 4609ChEBI: 16918 30778KNApSAcK: C00002647PDB-CCD: GDE3DMET: B00289NIKKAJI: J7.408J,121 C8y C 22.1200 -15.11272 C8x C 20.9090 -15.81123 C8x C 23.3375 -15.81124 C6a C 22.1137 -13.93235 C8y C 20.9090 -17.22086 C8y C 23.3375 -17.22087 O6a O 23.3182 -13.23388 O6a O 20.9025 -13.24019 C8y C 22.1200 -17.932210 O1a O 19.6978 -17.912811 O1a O 24.5485 -17.912812 O1a O 22.1137 -19.3290,121 1 2 22 1 3 13 1 4 14 2 5 15 3 6 26 4 7 17 4 8 28 5 9 29 5 10 110 6 11 111 9 12 112 6 9 1,,,R00053 R01637 R03247 R03297 R03549 R03550 R03551 R09271R09565 R12886,map00627 Aminobenzoate degradationmap00999 Biosynthesis of various plant secondary metabolitesmap01061 Biosynthesis of phenylpropanoidsmap01120 Microbial metabolism in diverse environments,1.13.11.3 1.13.11.8 1.13.11.57 2.1.1.3412.4.1.136 3.1.1.20 4.1.1.59,,,,,
D01544 Drug,Carboxymethylcellulose sodium (USP);Carmellose sodium (JP18);C.M.C. (TN);Celluvisc (TN),,C6H12O6. C2H3O2. Na,262.0665,262.1897,Gastrointestinal agentDG01770 Laxative,Therapeutic category: 2359Chemical structure group: DG01772Product (DG01772): D01544<JP>Product (mixture): D04802<JP>,"Laxative, Pharmaceutic aid (suspending, tablet excipient, viscosity-increasing)",,"Therapeutic category of drugs in Japan [BR:br08301]2 Agents affecting individual organs23 Digestive organ agents235 Purgatives, clysters2359 OthersD01544 Carboxymethylcellulose sodium (USP); Carmellose sodium (JP18)Risk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsInorganic and organic chemicalsCarmelloseD01544 Carboxymethylcellulose sodium (USP)Drug groups [BR:br08330]Gastrointestinal agentDG01770 LaxativeDG01772 CarmelloseD01544 Carboxymethylcellulose sodiumDrug classes [BR:br08332]Gastrointestinal agentDG01770 LaxativeD01544 Carboxymethylcellulose sodiumDrugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD01544 Carmellose sodiumDrug groups [BR:br08330]Gastrointestinal agentDG01770 LaxativeDG01772 Carmellose",CAS: 9004-32-4PubChem: 7848607ChEBI: 31357LigandBox: D01544NIKKAJI: J203.770J,171 C4a C 21.7650 -12.72372 C1c C 20.5546 -12.02293 C1c C 19.3441 -12.72374 C1c C 18.1337 -12.02295 C1c C 16.9232 -12.72376 C1b C 15.7128 -12.02297 O1a O 14.5023 -12.72378 O4a O 21.7650 -14.12539 O1a O 20.5546 -10.621410 O1a O 19.3441 -14.125311 O1a O 18.1337 -10.621412 O1a O 16.9232 -14.125313 C6a C 25.3900 -11.935414 C1a C 26.6041 -12.638115 O6a O 24.1820 -12.6381 #-16 O6a O 25.3900 -10.535617 Z Na 29.2137 -12.6934 #+,141 2 3 12 1 8 23 2 9 14 3 4 15 3 10 16 4 11 17 4 5 18 5 12 19 1 2 110 5 6 111 6 7 112 13 14 113 13 15 114 13 16 2,,,,,,,,,,
K10122 KO,fructooligosaccharide transport system permease protein,,,,,,,,,"KEGG Orthology (KO) [BR:ko00001]09180 Brite Hierarchies09183 Protein families: signaling and cellular processes02000 TransportersK10122 msmG; fructooligosaccharide transport system permease proteinTransporters [BR:ko02000]ABC transporters, prokaryotic typeSaccharide, polyol, and lipid transportersFructooligosaccharide transporterK10122 msmG; fructooligosaccharide transport system permease protein",COG: COG0395TC: 3.A.1.1.20,,,,,,,,,,msmG,BLI: BL01931BLD: BLi04180BLH: BaLi_c41720BSON: S101395_00211BSHI: LGQ02_03700BCAB: EFK13_13560BACQ: DOE78_11960 DOE78_22640BKW: BkAM31D_08140(araQ_2) BkAM31D_09555(araQ_3)HMN: HM131_05530 HM131_20055BMUR: ABE28_013565PFRI: L8956_01930GRC: GI584_19145 GI584_23465NDT: L1999_27010MEKU: HUW50_05835MSEM: GMB29_02965 GMB29_11010MLIT: KDJ21_006930RMF: D5E69_03935PMS: KNP414_01967PMQ: PM3016_2268PMW: B2K_11465PSAB: PSAB_09450 PSAB_14580PDU: PDUR_10645 PDUR_16355PAEN: P40081_29630PAEQ: R50912_26210PBJ: VN24_03640POW: IJ21_08500PLEN: EIM92_03315PSOP: KP014_13195 KP014_19645PTRI: KDC22_25575TCO: Theco_0592NTR: B0W44_12570LPK: LACPI_1522(msmG2)LCAR: BHS00_03585SPD: SPD_1583SPR: spr1618(ABC-MSP)SPX: SPG_1682SPV: SPH_1910SNM: SP70585_1847SPP: SPP_1794SNI: INV104_15340SPNG: HMPREF1038_01758SGO: SGO_1303SCF: Spaf_0604SIE: SCIM_1182SIB: SIR_0408(msmG)SLU: KE3_0108SIG: N596_00380SPLR: C0J00_02690LAC: LBA0504(msmG)LAD: LA14_0530LAF: SD55_0528(msmG)LCR: LCRIS_00500LJE: BUE77_00385OSI: DLJ48_04315TKR: C7K43_02030VTE: BHY08_02215VPI: BW732_02160VFV: K5K99_05935ADC: FOC79_01990CPR: CPR_0906(msmG)CBEI: LF65_04368CPAS: Clopa_3999CPAT: CLPA_c34230(araQ2)CPAE: CPAST_c34230(araQ2)CBV: U729_2055ROB: CK5_18130BYL: A4V09_03205BHAN: CGC63_15065BPRO: PMF13cell1_04823(araQ_51)LACY: A4V08_25245CBOL: CGC65_05575DLO: K5I24_11100TIT: Thit_2109EBM: SG0102_25580(ABC-MSP_2)BHC: JFL75_10995,"PMID:12847288AUTHORS Barrangou R, Altermann E, Hutkins R, Cano R, Klaenhammer TR.TITLE Functional and comparative genomic analyses of an operon involved in fructooligosaccharide utilization by Lactobacillus acidophilus.JOURNAL Proc Natl Acad Sci U S A 100:8957-62 (2003)DOI:10.1073/pnas.1332765100SEQUENCE [lac:LBA0504]"
D06333 Drug,Xanthan gum (NF);Rhodigel (TN),,,,,,,Pharmaceutic aid (suspending),,,CAS: 11138-66-2PubChem: 47207990NIKKAJI: J203.712B,,,,,,,,,,,,
C03323 Compound,"(2,1-beta-D-Fructosyl)n;(2,1-beta-D-Fructosyl)n+1;Inulin;(1,2-beta-D-Fructosyl)n;(1,2-beta-D-Fructosyl)m;(1,2-beta-D-Fructosyl)n+1;(1,2-beta-D-Fructosyl)m-1",,(C12H20O10)n,,,,Same as: D00171 G10497,,,"Therapeutic category of drugs in Japan [BR:br08301]7 Agents not mainly for therapeutic purpose72 Intracorporeal diagnostic agents722 Various function testing reagents7225 Diagnostic reagents for renal functionD00171 Inulin (JAN/USP)New drug approvals in Japan [br08318.html]Drugs with new active ingredientsD00171New drug approvals in the USA, Europe and Japan [br08328.html]Approval dates by FDA, EMA and PMDAD00171",CAS: 9005-80-5PubChem: 6172ChEBI: 15443NIKKAJI: J44.405G,241 C1z C 22.6800 -18.90002 O2x O 21.5600 -18.13003 O2a O 23.4500 -17.15004 C1y C 22.2600 -20.16005 C1a C 24.3600 -19.60006 C1y C 20.5100 -18.90007 C1b C 20.9300 -15.89008 C1y C 20.9300 -20.16009 O1a O 23.0300 -21.210010 Z * 28.6300 -19.670011 C1b C 19.3200 -18.480012 C1z C 19.0400 -15.190013 O1a O 20.1600 -21.210014 O1a O 18.4800 -19.530015 O2x O 17.9900 -14.420016 C1y C 18.6200 -16.450017 O1a O 18.7600 -13.230018 C1y C 16.8700 -15.190019 C1y C 17.3600 -16.450020 O1a O 19.4600 -17.500021 C1b C 15.6800 -14.770022 O1a O 16.5900 -17.500023 O1a O 14.9100 -15.820024 Z * 13.4400 -12.3200,251 1 2 12 1 3 1 #Up3 1 4 14 1 5 1 #Down5 2 6 16 3 7 17 4 8 18 4 9 1 #Up9 5 10 110 6 11 1 #Up11 12 7 1 #Down12 8 13 1 #Down13 11 14 114 12 15 115 12 16 116 12 17 1 #Up17 15 18 118 16 19 119 16 20 1 #Up20 18 21 1 #Up21 19 22 1 #Down22 21 23 123 6 8 124 18 19 125 17 24 1,,,R04193 R04194,map00500 Starch and sucrose metabolism,2.4.1.9 2.4.1.100,,1 15.4700 -14.2800 15.4700 -11.83001 25.7600 -18.6200 25.7600 -21.56001 nORIGINAL 1 1 2 3 4 5 6 7 8 9 11 12 13 14 15 16 171 18 19 20 21 22 23REPEAT 1,,,
D05355 Drug,Papain (USP);Caroid (TN),,,,,,,Enzyme (proteolytic),,,CAS: 9001-73-4PubChem: 47207037NIKKAJI: J209.232H,,,,See papain [EC:3.4.22.2] [KO:K06000],,,,,,,,
D07622 Drug,Carmellose (JP18/NF/INN);Croscarmellose (INN);Carboxymethylcellulose;CMC;Intrasite gel (TN),,C6H12O6. C2H4O2,240.0845,240.2078,Gastrointestinal agentDG01770 Laxative,Chemical structure group: DG01772Product (DG01772): D01544<JP>,"Laxative, Pharmaceutic aid (suspending, tablet excipient, viscosity-increasing)",,Risk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsInorganic and organic chemicalsCarmelloseD07622 Carmellose (JP18/NF/INN)Drug groups [BR:br08330]Gastrointestinal agentDG01770 LaxativeDG01772 CarmelloseD07622 CarmelloseDrugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD07622 CarmelloseDrug groups [BR:br08330]Gastrointestinal agentDG01770 LaxativeDG01772 Carmellose,CAS: 9000-11-7PubChem: 51091930ChEBI: 85146LigandBox: D07622,161 C4a C 24.0800 -18.34002 C1c C 22.8900 -17.64003 C1c C 21.6300 -18.34004 C1c C 20.4400 -17.64005 C1c C 19.2500 -18.34006 C1b C 17.9900 -17.64007 O1a O 16.8000 -18.34008 O4a O 24.0800 -19.74009 O1a O 22.8900 -16.240010 O1a O 21.6300 -19.740011 O1a O 20.4400 -16.240012 O1a O 19.2500 -19.740013 C6a C 27.7200 -17.570014 C1a C 28.9100 -18.270015 O6a O 26.4600 -18.270016 O6a O 27.7200 -16.1700,141 2 3 12 1 8 23 2 9 14 3 4 15 3 10 16 4 11 17 4 5 18 5 12 19 1 2 110 5 6 111 6 7 112 13 14 113 13 15 114 13 16 2,,bulk-forming,,,,,,,,
D00936 Drug,Calcium lactate (USP);Prequist powder (TN),,(C3H5O3)2. Ca. xH2O,,,Gastrointestinal agentDG01980 Calcium,ATC code: A12AA05Chemical structure group: DG00136Product (DG00136): D02254<JP>,"Antihypocalcemia, Supplement (calcium)",,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]A ALIMENTARY TRACT AND METABOLISMA12 MINERAL SUPPLEMENTSA12A CALCIUMA12AA CalciumA12AA05 Calcium lactateD00936 Calcium lactate (USP)Classification of Japanese OTC drugs [BR:br08313]Nourishing tonics and health supplements44 Calcium based drugsD00936 Calcium lactate (USP)Risk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsInorganic and organic chemicalsCalcium lactateD00936 Calcium lactate (USP)Drug groups [BR:br08330]Gastrointestinal agentDG01980 CalciumDG00136 Calcium lactateD00936 Calcium lactateDrug groups [BR:br08330]Gastrointestinal agentDG01980 CalciumDG00136 Calcium lactate,CAS: 41372-22-9PubChem: 7847999LigandBox: D00936NIKKAJI: J244.492E,141 O0 O 32.0250 -17.89582 C1c C 21.8295 -18.16893 C6a C 23.0380 -17.48014 C1a C 21.8235 -19.57605 O1a O 20.6152 -17.47426 O6a O 23.0321 -16.07907 O6a O 24.2523 -18.1806 #-8 Z Ca 27.1882 -18.0230 #2+9 C1c C 21.8295 -18.168910 C6a C 23.0380 -17.480111 O6a O 23.0321 -16.079012 O6a O 24.2523 -18.1806 #-13 C1a C 21.8235 -19.576014 O1a O 20.6152 -17.4742,101 2 3 12 2 4 13 2 5 14 3 6 25 3 7 16 9 10 17 9 13 18 9 14 19 10 11 210 10 12 1,,x=5 [DR:D02254],,,,,1 30.1000 -18.9700 30.1000 -16.87001 32.4800 -16.8700 32.4800 -18.97001 xORIGINAL 1 1REPEAT 12 18.7600 -20.7200 18.7600 -15.19002 25.2700 -15.1900 25.2700 -20.72002 2ORIGINAL 2 2 3 6 7 4 5REPEAT 2 9 10 11 12 13 14,,,
D02060 Drug,Potassium chloride (JP18/USP);K-dur (TN);KCL (TN);Kaon-Cl (TN);Klor-con (TN);Klotrix (TN),POTASSIUM CHLORIDE (ATLANTIC BIOLOGICALS CORP.) cc912caf-f4d9-4c08-ba9f-45c5e8ed8060K-TAB (AbbVie) 6594df99-d8ce-49b9-3fbe-9ec7cdc9199bPOTASSIUM CHLORIDE (Aphena Pharma Solutions - Tennessee) 81a53ecd-2612-4efe-9491-415fff3f86e5KLOR-CON (Aphena Pharma Solutions - Tennessee) e02f9d3e-d744-4020-b90c-215f2ae69e16POTASSIUM CHLORIDE (AvKARE) 8bb030b7-104a-373b-e053-2995a90ab580POTASSIUM CHLORIDE (Baxter Healthcare Corporation) 092ddee4-572d-4771-8d95-880cea01097ePOTASSIUM CHLORIDE (Clinical Solutions Wholesale) 850b5b94-05a7-468c-8b90-77a1d45cd5c1POTASSIUM CHLORIDE (DIRECT RX) f5adfe63-62a8-4453-a0f0-db3076e01d78POTASSIUM CHLORIDE (Genus Lifesciences) 14cd12ee-a4a3-465a-9550-58c9ef0e4f21POTASSIUM CHLORIDE (Genus Lifesciences) 23d818e7-c076-40de-8dc1-0b51ba4be96aPOTASSIUM CHLORIDE (ICU Medical) eb56a807-ea94-4edb-9811-a04b19568468POTASSIUM CHLORIDE (NCS HealthCare of KY) e3fad0ed-6c46-4555-a0b0-8cbb4f5b99e1POTASSIUM CHLORIDE (NuCare Pharmaceuticals) 65a98025-540e-b45f-e053-2991aa0a003ePOTASSIUM CHLORIDE (NuCare Pharmaceuticals) 7f316427-932e-fd30-e053-2991aa0af850POTASSIUM CHLORIDE (Par Pharmaceutical) a64d7151-09a6-474c-83fc-36c7cf582d32POTASSIUM CHLORIDE (Par Pharmaceutical) e5214432-3517-4a90-9412-036752bd1139POTASSIUM CHLORIDE (Proficient Rx LP) 034d279c-05e4-496e-9fc6-058dae158c60POTASSIUM CHLORIDE (REMEDYREPACK) 99711cce-7e88-4adf-b0f8-245e8b8a62d6POTASSIUM CHLORIDE (RPK Pharmaceuticals) 92505c43-662d-41ea-8c31-e5789ec3ff7fPOTASSIUM CHLORIDE (RedPharm Drug) 89095e99-121b-2fb9-e053-2995a90ac7fbKLOR-CON (Upsher-Smith Laboratories) 1ff53330-065c-4213-9c0c-ac498621d09dPOTASSIUM CHLORIDE (Upsher-Smith Laboratories) 616f0de7-8843-44a1-8fa6-274d889286aaPOTASSIUM CHLORIDE FOR ORAL SOLUTION (Virtus Pharmaceuticals) 6b03df7d-a50b-4029-8141-bbd26d5ec071POTASSIUM CHLORIDE (VistaPharm) 142c30ff-a839-4616-8167-ad4b07d8456fGENERIC POTASSIUM CHLORIDE (A-S Medication Solutions) 0809c315-9242-4c83-b5c3-f302760451fdPOTASSIUM CHLORIDE (A-S Medication Solutions) 104f2111-1a4b-48db-9493-5d36b5db5627POTASSIUM CHLORIDE (A-S Medication Solutions) 238ca94a-d9f0-4747-801d-3af879cf570fPOTASSIUM CHLORIDE (A-S Medication Solutions) 5aa0adf8-7b84-4cb0-be31-5c3333a6cc44POTASSIUM CHLORIDE (A-S Medication Solutions) 6ac47b4d-8f4c-441f-88bc-cd34e4c56280POTASSIUM CHLORIDE (A-S Medication Solutions) 87cc7349-5a07-4a39-be97-4e1013814f30POTASSIUM CHLORIDE (A-S Medication Solutions) 926e05bf-7f26-4817-a28f-422f7e2e1510KLOR-CON M20 (A-S Medication Solutions) aee428c1-897e-455c-beee-2f81b27014a7POTASSIUM CHLORIDE (A-S Medication Solutions) e1670127-c551-441b-bac4-39f10a6d156fPOTASSIUM CHLORIDE (AMTA LABS LIMITED) ebbece9e-b112-410b-8a6f-db087c42263cPOTASSIUM CHLORIDE (Actavis Pharma) 0c0a180b-f4f4-4122-9e29-ac7160a9f519POTASSIUM CHLORIDE (Actavis Pharma) 21f23d9c-6b09-4970-9e2b-1325654b250bPOTASSIUM CHLORIDE (Actavis Pharma) db002ae3-f54c-40a4-9cb4-e5681bf426e3POTASSIUM CHLORIDE (Actavis Pharma) ed5baaf6-270b-4dd3-b100-36030c0098fcPOTASSIUM CHLORIDE (Adare Pharmaceuticals) 22edb0e6-4e45-4e91-aead-3581cca293a0POTASSIUM CHLORIDE (Advagen Pharma Limited) a9e9d134-55d0-47ae-925f-de07e7ffa4b8POTASSIUM CHLORIDE (Advagen Pharma Limited) d528c0c1-b81f-4f7a-8518-e6911b23c3ebPOTASSIUM CHLORIDE (Advagen Pharma) 8000e242-fe20-4d02-8f7d-97298857cf4cPOTASSIUM CHLORIDE (American Health Packaging) 77514052-7056-4530-a38d-c05d209b13a7POTASSIUM CHLORIDE (American Health Packaging) 7956883f-0d31-4081-bbea-d9ea320a193bPOTASSIUM CHLORIDE EXTENDED-RELEASE (American Health Packaging) 8c12c5f8-5950-44e3-9473-a0b95187b43cPOTASSIUM CHLORIDE (American Health Packaging) 96ea00f5-b922-4d57-b2ac-34523ea56d5fPOTASSIUM CHLORIDE (American Health Packaging) 9b75e082-addd-4eae-a016-ca36ffc791f2POTASSIUM CHLORIDE (American Health Packaging) c1024e6d-1a91-4609-b1a8-e5ef898c15a4POTASSIUM CHLORIDE (American Health Packaging) f8a8f33b-2e58-4990-beb4-c8b025e0147fPOTASSIUM CHLORIDE (Amneal Pharmaceuticals NY LLC) 590dd25c-c4cb-489a-a09b-eccbf1d37c1fPOTASSIUM CHLORIDE (Amneal Pharmaceuticals NY LLC) a0bed01f-cf33-4a2f-b9ae-1cbb2f85665fPOTASSIUM CHLORIDE (Amneal Pharmaceuticals NY LLC) ef081d58-f106-4c1b-82a9-01d396d40632POTASSIUM CHLORIDE (Amneal Pharmaceuticals of New York LLC) cd56e147-92d6-46ce-ae00-63fac08d49b5POTASSIUM CHLORIDE (Aphena Pharma Solutions - Tennessee) 61fe55c2-fc9a-4fae-899a-06601baa78e1POTASSIUM CHLORIDE (Aphena Pharma Solutions - Tennessee) d2e84d34-e042-477f-9944-3fcb95301217KLOR-CON M (Aphena Pharma Solutions - Tennessee) f898ea0e-96ad-4fe3-a72a-5089c3cf4facPOTASSIUM CHLORIDE (Apotex Corp) 18ab4157-e99a-bff3-9ef8-9bb5c32ca36bPOTASSIUM CHLORIDE (Ascent Pharmaceuticals) c47c0704-26f1-41ba-8af6-50250686d612POTASSIUM CHLORIDE (Aurobindo Pharma Limited) d43beabe-b801-4319-ad36-9a80856b94bdPOTASSIUM CHLORIDE (Aurobindo Pharma Limited) deb6b462-397f-4527-ae26-40dc5d5857bcPOTASSIUM CHLORIDE (AvKARE) 755a4a08-04ff-d7d1-a6fc-b8aeff3ae2c6POTASSIUM CHLORIDE (AvKARE) 8baf3f25-c78b-6c08-e053-2995a90a667ePOTASSIUM CHLORIDE (AvPAK) 6bb3f62d-79ce-cee6-8c6c-ee1eb6121f01POTASSIUM CHLORIDE (B. Braun Medical) ab67b151-8368-4321-b562-bad5eff7b740POTASSIUM CHLORIDE (B. Braun Medical) fbced30a-925d-4fc8-8db6-d54489e3752dPOTASSIUM CHLORIDE (BluePoint Laboratories) 380800ac-8cce-44fe-96aa-e8d4f872d2f3POTASSIUM CHLORIDE (BluePoint Laboratories) 431ff2ef-567c-4b60-af43-f4da61febaadPOTASSIUM CHLORIDE (BluePoint Laboratories) 73c911bb-4d39-4793-acba-90ed4b0eff46POTASSIUM CHLORIDE (BluePoint Laboratories) c75665fb-0a99-4766-84a4-254987db6908POTASSIUM CHLORIDE (Bora Pharmaceutical Laboratories) a82a2cee-9c6e-6a3a-e053-2a95a90a74f3POTASSIUM CHLORIDE (Bryant Ranch Prepack) 0e875691-7372-46ac-80a1-946e08b40061POTASSIUM CHLORIDE (Bryant Ranch Prepack) 2de8483d-5c67-4b67-b5ab-3ae8d6c102cePOTASSIUM CHLORIDE (Bryant Ranch Prepack) 418fa94a-9e92-4f06-b8c2-020c885e3412POTASSIUM CHLORIDE EXTENDED RELEASE (Bryant Ranch Prepack) 41ff55cf-4af3-487e-bd78-09703d310780POTASSIUM CHLORIDE (Bryant Ranch Prepack) 43e78f6e-a5a9-4c14-96cd-b28d7179adbfPOTASSIUM CHLORIDE EXTENDED-RELEASE (Bryant Ranch Prepack) 473369cb-3a9b-437c-b08e-8fb38034c507POTASSIUM CHLORIDE EXTENDED-RELEASE (Bryant Ranch Prepack) 55747ef3-9437-4bdc-9ebd-a74d8e2de1cfPOTASSIUM CHLORIDE (Bryant Ranch Prepack) 5a8565cb-6d97-496a-b40c-47c56a13a113POTASSIUM CHLORIDE (Bryant Ranch Prepack) 65e30d1a-50e9-4b84-ad4d-daaea91eab4bPOTASSIUM CHLORIDE (Bryant Ranch Prepack) 6766515e-12f9-4c45-977c-e099c74fe931POTASSIUM CHLORIDE (Bryant Ranch Prepack) 6ffe7c89-848b-42b4-8608-269c9c9202a1POTASSIUM CHLORIDE EXTENDED-RELEASE (Bryant Ranch Prepack) 7427c29e-55c1-4c30-b091-058c8bec592fPOTASSIUM CHLORIDE (Bryant Ranch Prepack) 772cbb58-676c-4f9e-9ebe-0756b5c3eaabPOTASSIUM CHLORIDE EXTENDED-RELEASE (Bryant Ranch Prepack) 80dd5de2-5066-472b-b1f8-88070a5c7388POTASSIUM CHLORIDE (Bryant Ranch Prepack) 82f58728-de08-45b2-ad05-3590ea0202e6POTASSIUM CHLORIDE (Bryant Ranch Prepack) 867849ee-51ae-47fc-8b52-f889fd645895POTASSIUM CHLORIDE EXTENDED RELEASE (Bryant Ranch Prepack) 8a40e183-dba9-4353-bbea-578925d3b071POTASSIUM CHLORIDE (Bryant Ranch Prepack) 91ab68a1-b7cb-4dec-98a2-f30f099c020bPOTASSIUM CHLORIDE (Bryant Ranch Prepack) ab147ac2-d7d5-46d1-a2de-d866219197c1POTASSIUM CHLORIDE EXTENDED-RELEASE (Bryant Ranch Prepack) b5a6b6f2-d073-4bd3-a66c-bf34ccabfe51POTASSIUM CHLORIDE (Bryant Ranch Prepack) bc42a691-a486-4ece-b9f7-faf6cc5df6b5POTASSIUM CHLORIDE (Bryant Ranch Prepack) d396477a-6b15-4782-9c85-b9663b83c484POTASSIUM CHLORIDE EXTENDED RELEASE (Bryant Ranch Prepack) e45eb81a-a415-4ca9-adb4-31198047b249POTASSIUM CHLORIDE (Bryant Ranch Prepack) f22606a5-ac9f-44fc-bb7b-08f3cf56c999POTASSIUM CHLORIDE (Camber Pharmaceuticals) b1e827aa-b2fb-4fa5-984d-ddd94338ff53POTASSIUM CHLORIDE EXTENDED RELEASE (Cardinal Health) 446ad1bd-cf5c-41a7-945f-a6575cab16bfPOTASSIUM CHLORIDE (Cardinal Health) 6ed04120-c734-4316-82eb-2adf4d3593feKLOR-CON M (Cardinal Health) ee3a1815-7325-4838-9764-fe1db68877b6POTASSIUM CHLORIDE (Cardinal Health 107) 83ef4d53-9ab8-47f6-af45-155ea3fed95bPOTASSIUM CHLORIDE (Centaur Pharmaceuticals Private Limited) 8aeea3d0-d0b0-4db7-a649-dd935837921fPOTASSIUM CHLORIDE (DIRECT RX) 7c2ca555-1e74-43bb-bbda-58518c4dab29POTASSIUM CHLORIDE (DOH CENTRAL PHARMACY) b917235f-7989-4570-9532-fc5ff0468784POTASSIUM CHLORIDE (Denton Pharma) d1029f0e-dc86-a45d-e053-2a95a90a1c74POTASSIUM CHLORIDE (Denton Pharma) d102d052-8052-8ccb-e053-2a95a90a1735POTASSIUM CHLORIDE (Denton Pharma) dfdc7e90-8067-4a4b-e053-2a95a90ad8a8POTASSIUM CHLORIDE (Direct_Rx) 946b9568-671d-172a-e053-2a95a90ac827POTASSIUM CHLORIDE (Dr. Reddy's Laboratories) dda82a38-0c08-4947-99b7-915c2949bf16POTASSIUM CHLORIDE (Epic Pharma) 1373321f-533a-4ab4-8bcd-8bde15371a09POTASSIUM CHLORIDE (Fresenius Kabi USA) 3849b89c-c309-46fb-a1e2-53ff0c65077fPOTASSIUM CHLORIDE (Fresenius Kabi USA) fcd4f458-ce27-417e-9bb6-de1cc49d44b9POTASSIUM CHLORIDE (General Injectables & Vaccines) f46f2b60-a7d1-4da1-a7e5-5dd80c3ec9c4POTASSIUM CHLORIDE (General Injectables & Vaccines) 46c162d4-0af9-4d14-8781-941a9117428cPOTASSIUM CHLORIDE (General Injectables and Vaccines) 8060657d-b027-479b-a6ec-e176dde84dfbPOTASSIUM CHLORIDE (Glenmark Pharmaceuticals) 5b054142-7372-4641-be27-dca630a97ad9POTASSIUM CHLORIDE (Glenmark Pharmaceuticals) 63bedd99-0596-49d2-ad04-d1d8ac15cc42POTASSIUM CHLORIDE (Granules Pharmaceuticals) c1f4832d-4d5c-8c49-e053-2a95a90ac9fePOTASSIUM CHLORIDE EXTENDED RELEASE (Granules Pharmaceuticals) 9f8d2886-9ecd-4cbf-a84a-2d221cb3497cPOTASSIUM CHLORIDE (HF Acquisition Co LLC) 9508355e-e1ed-412b-e053-2a95a90aac8ePOTASSIUM CHLORIDE (HF Acquisition Co LLC) 951ffdc3-d54f-d5e1-e053-2a95a90a79e6POTASSIUM CHLORIDE (Henry Schein) 8367a2ae-dfd9-4515-838c-529920291ca0POTASSIUM CHLORIDE (Henry Schein) bf8e8ac7-e6a8-4571-a0ea-7bcab89290f6POTASSIUM CHLORIDE (Hospira) 559a0a8c-a8fe-40a5-b196-21f9308780abPOTASSIUM CHLORIDE (Lohxa) 843a7b4e-e549-4f29-8f1a-60671617a0c0POTASSIUM CHLORIDE (Lupin Pharmaceuticals) 1f33bcfe-c28a-4800-9241-685d974a5d91POTASSIUM CHLORIDE (Lupin Pharmaceuticals) 1bbacdbb-91fa-4897-a00c-1b293de27b83POTASSIUM CHLORIDE (Lupin Pharmaceuticals) 28c49165-d8c9-443a-b000-953b8e1ec55cPOTASSIUM CHLORIDE (Lupin Pharmaceuticals) fe08221d-74d5-490a-8db4-eaf3ed20b289POTASSIUM CHLORIDE (MICRO LABS LIMITED) 8c4bc063-4d04-48f0-8e62-0252a69673d0POTASSIUM CHLORIDE (Major Pharmaceuticals) 327cf9ad-8578-4ee3-9c93-3cf1d17e5197POTASSIUM CHLORIDE (Major Pharmaceuticals) 365d452b-728f-4fc6-81c9-7e17e18e796dPOTASSIUM CHLORIDE (Major Pharmaceuticals) 4732f78f-ed64-4278-9a6a-8f248c37c036POTASSIUM CHLORIDE (Major Pharmaceuticals) 6ae34cdf-4f32-4719-b52a-e2a7612f5f40POTASSIUM CHLORIDE (Major Pharmaceuticals) a9d68a40-75e3-4c5c-b5d7-1d6160527fa7POTASSIUM CHLORIDE (Major Pharmaceuticals) cba5627a-dadc-45f1-b531-4e23549cc518POTASSIUM CHLORIDE (McKesson Corporation dba as SKY Packaging) 8823d4b5-3766-454d-912c-eec3b008ab09POTASSIUM CHLORIDE (Mckesson Corporation DBA SKY Packaginng) 5cccc39f-6a6d-415e-a55f-f4ee57f72a0aPOTASSIUM CHLORIDE (Mylan Pharmaceuticals) c64ed4c0-1e27-42b3-9625-fb4e0d31e271POTASSIUM CHLORIDE (NCS HealthCare of KY) 77ad608d-0469-469d-9021-fd75aa769921POTASSIUM CHLORIDE (Nexus Pharamaceuticals) 765ef38c-df36-46d1-9062-61e30ff46a86POTASSIUM CHLORIDE (Northstar Rx LLC) dded25a9-3df4-463a-8685-d2bc03ea4edbPOTASSIUM CHLORIDE (Novel Laboratories) 1562b0a4-d87a-4245-9219-587b38b16c8dPOTASSIUM CHLORIDE (Novel Laboratories) 5bc4e170-9088-46ba-ade4-05b6027da6c4POTASSIUM CHLORIDE (Novel Laboratories) ce4d4d39-8551-4789-8347-af763635922cPOTASSIUM CHLORIDE (Novel Laboratories) d0f24788-3a28-470c-acf4-2bc5397ae3bePOTASSIUM CHLORIDE (Novel Laboratories) eb82527d-88e5-4599-a81a-b3d3144eea19POTASSIUM CHLORIDE (NuCare Pharmaceuticals) 40ba25e2-981d-3454-e054-00144ff8d46cPOTASSIUM CHLORIDE (NuCare Pharmaceuticals) 4a404aab-c878-4597-e054-00144ff88e88POTASSIUM CHLORIDE (NuCare Pharmaceuticals) 7f9adc84-8795-3723-e053-2a91aa0ac82dPOTASSIUM CHLORIDE (NuCare Pharmaceuticals) 8ed46f5f-4d9d-3e54-e053-2995a90a21b3POTASSIUM CHLORIDE (PD-Rx Pharmaceuticals) 35a1b03f-9716-4970-b9c2-998aa0923924POTASSIUM CHLORIDE (PD-Rx Pharmaceuticals) 42937afb-8776-407e-a7b5-1fafd0a88344POTASSIUM CHLORIDE (PD-Rx Pharmaceuticals) af7ef02a-1a51-4747-b4a0-7e270136f161POTASSIUM CHLORIDE (PD-Rx Pharmaceuticals) be7eccf9-b1a4-4442-820c-c3199946f26fPOTASSIUM CHLORIDE (PD-Rx Pharmaceuticals) cc15ef60-6956-4d34-b86d-72cdd0c0c0bbPOTASSIUM CHLORIDE (PD-Rx Pharmaceuticals) ccaaa3a2-a273-41c7-9e54-429539ea0140POTASSIUM CHLORIDE (Padagis US LLC) d5163535-ae09-4efb-97ef-532789cd7540POTASSIUM CHLORIDE EXTENDED RELEASE (Padagis US LLC) ef2f9647-00b5-439c-9ec6-2cbfe6bf3f3dPOTASSIUM CHLORIDE (Pharmaceutical Associates) c13b96ff-0a31-4e29-bbee-728216d3c5ffPOTASSIUM CHLORIDE (Preferred Pharmaceuticals) 3f19ed0e-6c73-482c-94d6-d3205318fd6fPOTASSIUM CHLORIDE (Preferred Pharmaceuticals) d35ad4e2-94c3-403a-997e-cc488be276c3POTASSIUM CHLORIDE (Preferred Pharmaceuticals) a0adbd12-c9ab-4f16-b40f-81ed210c36e1POTASSIUM CHLORIDE EXTENDED RELEASE (Proficient Rx LP) 10d71ce7-ecb0-458d-b987-b9abd97cbab4POTASSIUM CHLORIDE (Proficient Rx LP) 70d3497a-1144-47f2-a924-aec8a9881dbdPOTASSIUM CHLORIDE (Proficient Rx LP) 956e602f-772d-441e-9bf5-d1560c5b9615POTASSIUM CHLORIDE (Quality Care Products) f2b51045-a5b4-4d78-8765-3462f424e5c2POTASSIUM CHLORIDE (REMEDYREPACK) 10ae6094-3554-4d4e-af36-4cf930e7e2e9POTASSIUM CHLORIDE (REMEDYREPACK) 16c775e4-0dd8-4e9f-b2bf-dd2b639374cfPOTASSIUM CHLORIDE (REMEDYREPACK) 1c553862-cefb-4d6d-aaca-ba8b71ccb749POTASSIUM CHLORIDE (REMEDYREPACK) 4270cce8-4cbb-4d67-a4cb-f073ef554d12KLOR-CON M (REMEDYREPACK) 480fa992-5ba7-46bc-9887-bc98c9350b30POTASSIUM CHLORIDE (REMEDYREPACK) 4c90f167-9684-4a68-8af7-f7f1e8718f86POTASSIUM CHLORIDE (REMEDYREPACK) 62c2d8d7-1d90-4ae7-a6ff-6fc28f13e594POTASSIUM CHLORIDE (REMEDYREPACK) 77d8d04b-dd5a-4cf1-8740-53e65c13014dPOTASSIUM CHLORIDE EXTENDED-RELEASE (REMEDYREPACK) 7ec22e8e-6643-44fe-804d-ca0b0b266663POTASSIUM CHLORIDE (REMEDYREPACK) 861c568f-0edb-41fd-8e7c-b8a489a5910dPOTASSIUM CHLORIDE (REMEDYREPACK) b39640f1-c851-4f69-a280-4c6fdd97847bPOTASSIUM CHLORIDE (RPK Pharmaceuticals) 495e8de7-41c1-40fc-8af5-3c5480716119POTASSIUM CHLORIDE (RPK Pharmaceuticals) 71e656a0-24ff-4c44-898d-22f4fc497b74POTASSIUM CHLORIDE (RedPharm Drug) 4e180cd5-2fd2-5047-e054-00144ff88e88POTASSIUM CHLORIDE (RedPharm Drug) a344a6e7-77e4-4a78-e053-2995a90a0392POTASSIUM CHLORIDE (RedPharm Drug) b327eec5-144d-1122-e053-2a95a90a85f5POTASSIUM CHLORIDE (Safecor Health) ed446e4b-b438-44c1-b42d-5701963d2ac7POTASSIUM CHLORIDE (Slate Run Pharmaceuticals) 0cc57ece-f15a-4160-a5ea-8d6fa9f9e754POTASSIUM CHLORIDE (Slate Run Pharmaceuticals) 94ae03cc-b620-0dbb-e053-2a95a90a922cPOTASSIUM CHLORIDE (Solco Healthcare LLC) 52d91d76-8c7f-40f1-9f5c-e05962cabeddPOTASSIUM CHLORIDE (St Marys Medical Park Pharmacy) fbba72ae-9128-418e-9e60-5c17e2644b7aPOTASSIUM CHLORIDE (St Marys Medical Park Pharmacy .) 74883ca9-e9cf-4556-929d-72c53f0478acPOTASSIUM CHLORIDE (St. Mary's Medical Park Pharmacy) 8d442ef6-d507-0967-e053-2995a90a55e0POTASSIUM CHLORIDE (St. Mary's Medical Park Pharmacy) afeb4aa6-24db-7ed9-e053-2a95a90a16fcPOTASSIUM CHLORIDE (Strides Pharma Science Limited) 0224e5b3-3c49-4e6e-aa78-1abcc6969246POTASSIUM CHLORIDE (Strides Pharma Science Limited) f4e36462-3522-4130-8785-6c18871d2984POTASSIUM CHLORIDE (Sun Pharmaceutical Industries) 4d90d03d-7f0e-4d49-9e80-628dbc7165c0POTASSIUM CHLORIDE EXTENDED-RELEASE (Sun Pharmaceutical Industries) 8ed8ea55-8b15-f718-e053-2a95a90a587aPOTASSIUM CHLORIDE (Tris Pharma) 159ddd0b-847e-4ecc-b3b2-9634cbb4dfa9KLOR-CON M (Upsher-Smith Laboratories) b89910f6-4ff5-4a62-8269-696f7c10e4f6KLOR-CON SPRINKLE (Upsher-Smith Laboratories) dd21287c-001f-42ec-a2de-01fefe5cc5aaKLOR-CON (Upsher-Smith Laboratories) e61a4522-b91d-400a-952c-6f035e4610ddPOTASSIUM CHLORIDE (Upsher-SmithLaboratories) ad584ce4-a64d-4851-80e9-0eeedc0b9d06POTASSIUM CHLORIDE (Virtus Pharmaceuticals) b43b84ea-babd-477b-b69b-811657bc1503POTASSIUM CHLORIDE (Vitruvias Therapeutics) 2391d8fc-d9e0-4efe-9502-2ef0816dfad2POTASSIUM CHLORIDE (XLCare Pharmaceuticals) 7fd82f08-8ad0-4ee2-8eb6-5c973f98baeePOTASSIUM CHLORIDE (Zydus Pharmaceuticals (USA)) 51586c47-1aff-4ce6-8030-89f9eb1bc9acPOTASSIUM CHLORIDE (Zydus Pharmaceuticals USA) 8d140d5e-a5d7-5302-3572-e606dd247410POTASSIUM CHLORIDE (NuCare Pharmaceuticals) 5828e241-9406-7341-e053-2991aa0a41f7POTASSIUM CHLORIDE EXTENDED-RELEASE (Bryant Ranch Prepack) 7b8e7a4f-0d44-46b2-9565-7b4c294e9fcbPOTASSIUM CHLORIDE EXTENDED-RELEASE (Granules India) 60285a8d-bcb0-40ba-b359-df5c89480cd6POTASSIUM CHLORIDE EXTENDED-RELEASE (Granules Pharmaceuticals) b3d4d5b5-2898-ae3d-e053-2a95a90a6d04POTASSIUM CHLORIDE EXTENDED-RELEASE (NCS HealthCare of KY) c684758c-16f0-4bd9-b719-1aae64b7907fPOTASSIUM CHLORIDE EXTENDED-RELEASE (Preferred Pharmaceuticals) 87f369cf-40e5-4f91-aa42-ae986fce6544POTASSIUM CHLORIDE EXTENDED-RELEASE (REMEDYREPACK) d56509d3-e6b9-4070-b009-da057c6513c4POTASSIUM CHLORIDE (Solco Healthcare LLC) f704b746-ab75-4484-8704-5baa94a07750POTASSIUM CHLORIDE FOR ORAL SOLUTION (BPI Labs LLC) 1ea4345e-f8bb-4d41-9003-c87b21169d7cPOTASSIUM CHLORIDE FOR ORAL SOLUTION (Belcher Pharmaceuticals LLC) 0e4fd822-9167-4451-b8fe-9a63e09f7ed1,K. Cl,73.9326,74.5513,Gastrointestinal agentDG02017 Potassium,Therapeutic category: 3229 3319ATC code: A12BA01 B05XA01Product: D02060<JP/US>Product (mixture): D04109<JP> D04113<JP> D04424<JP> D04981<JP> D05329<JP/US> D07703<JP> D08814<JP> D08816<JP> D11174<JP> D11552<US>,"Supplement (potassium), Replenisher (electrolyte)DISEASE Hypokalemic familial periodic paralysis [DS:H00746]",,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]A ALIMENTARY TRACT AND METABOLISMA12 MINERAL SUPPLEMENTSA12B POTASSIUMA12BA PotassiumA12BA01 Potassium chlorideD02060 Potassium chloride (JP18/USP) &lt;JP/US&gt;B BLOOD AND BLOOD FORMING ORGANSB05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONSB05X I.V. SOLUTION ADDITIVESB05XA Electrolyte solutionsB05XA01 Potassium chlorideD02060 Potassium chloride (JP18/USP) &lt;JP/US&gt;USP drug classification [BR:br08302]Electrolytes/Minerals/Metals/VitaminsElectrolyte/Mineral ReplacementPotassiumD02060 Potassium chloride (JP18/USP)Therapeutic category of drugs in Japan [BR:br08301]3 Agents affecting metabolism32 Nutrients, tonics322 Mineral preparations3229 OthersD02060 Potassium chloride (JP18/USP)33 Blood and body fluid agents331 Blood substitutes3319 OthersD02060 Potassium chloride (JP18/USP)Classification of Japanese OTC drugs [BR:br08313]Agents for ophthalmologic use65 Artificial tearD02060 Potassium chloride (JP18/USP)Risk category of Japanese OTC drugs [BR:br08312]Third-class OTC drugsInorganic and organic chemicalsPotassium chlorideD02060 Potassium chloride (JP18/USP)Drug groups [BR:br08330]Gastrointestinal agentDG02017 PotassiumD02060 Potassium chlorideDrugs listed in the Japanese Pharmacopoeia [BR:br08311]ChemicalsD02060 Potassium chloride",CAS: 7447-40-7PubChem: 7849122ChEBI: 32588NIKKAJI: J3.740K,21 Z K 21.8400 -16.1467 #+2 X Cl 24.7333 -16.1467 #-,0,,,,,,,,,,
